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ABSTRACT
This thesis examines the structure and regulated expression of the gene
encoing the neuroendocrine peptides neurotensin and neuromedin N (NT/N gene).
Previous studies have shown that expression of NT/N mRNA and NT peptide in
PC12 cells are strictly dependent on simultaneous exposure to combinations of
nerve growth factor (NGF), glucocorticoids, activators of adenylate cyclase, and
lithium ion. My objective was to characterize the cis-regulatory DNA sequences
involved in regulated expression of this gene.
The initial focus of this study was an analysis of the structure, tissue-specific
expression, and exon evolution of the rat NT/N gene. Nucleotide sequence
comparisons between the rat gene and the canine and bovine cDNA sequences
indicated that the predicted structure of a 170 amino acid precursor protein is
highly conserved. Furthermore, the close similarity between the two cDNAs
suggested that identical precursor proteins are expressed in neural and endocrine
tissues. RNA analysis revealed that the gene is transcribed to yield two distinct
mRNAs, 1.0 kb and 1.5 kb in size. The two mRNA species differ only in the size of
their 3' untranslated regions. Interestingly, the smaller mRNA is predominant in
the gastrointestinal tract, while both mRNAs are equally abundant in all neural
tissues examined, except the cerebellum, where no expression was observed.
Transient transfection assays were used to delineate the rat NT/N gene cis-
regulatory DNA sequences. Progressive deletion of the NT/N 5' flanking region
revealed that sequences between -216 and +56 of the NT/N gene are sufficient to
confer the full spectrum of responses of the endogenous gene to either of two
reporter genes. A detailed mutational analysis of the NT/N control region
viii
indicated that it is composed of an array of inducible cis-regulatory elements,
including an AP-1 site, two cAMP-responsive elements (CREs), and a
glucocorticoid-responsive element (GRE). Specific mutations to the AP-1 site
and either CRE suggested that these elements are functionally interdependent. I
propose that this array of cis-regulatory sequences in the NT/N transcriptional
control region serves to integrate multiple environmental stimuli into a unified
transcriptional response.
To further examine the role of the AP-1 site and CREs in the NT/N promoter,
reporter genes containing either a single or multiple AP-1 or CRE sites were
expressed in PC12 cells and protein kinase A-deficient PC12 cells treated with
forskolin, NGF, and lithium, either individually, or in combination. The results
indicated that lithium and NGF markedly activate promoters containing multiple
AP-1 sites, but not a single site, and that these effects were additive. Both agents
potentiated forskolin- induced activation of promoters containing a single or
multiple CREs, but had no effect, individually. Also, in contrast to the activation
of multiple AP-1 sites by lithium and NGF, activation of the NT/N promoter and
promoters containing CREs is absolutely dependent on protein kinase A activity.
These results suggested that promoters containing multiple AP-1 sites, or a
single AP-1 site in the context of nearby active CREs, are selectively activated by
lithium and NGF in PC12 cells.
Based on the results of this thesis I have proposed a model to account for the
complex transcriptional regulation of the NT/N gene in PC12 cells. I have also
addressed the relevance of these findings to the mechanisms of phenotypic
plasticity of embryonic neural crest cells, NGF- induced neuronal differentiation
and the pharmacological actions of lithium.
TABLE OF CONTENTS
TIT PAGE
COYRIGH PAGE
APOVAL PAGE iii
ACOWLDMENTS
ABCT vii
TAB OF COENS
UST OF FIGURES xii
COTCR xiv
CHAPTER I:
INTRODUCTION
OVERVIEW
NEURAL CREST: A MODEL FOR PHENOTYPIC PLASTICITY
CELLULAR RESPOSES TO ENVIRONMENTAL STIMUU
NEUROTESIN
NEUROTENSIN REGULATION IN PC 12 CELLS
NERVE GROW FACTOR
CYCUC AMP
LITHIUM ION
GLLDS
EXPERIMENAL APPROACH
COPENDIUM OF MAUSCRIPTS
CHAPTER 1\:
THE RAT GENE ENCODING NEUROTEN AND NEUROMEDIN N:
STRUCTURE, TISSUE-5PECIAC EXPRESSION, AND EVOLUTION OF EXON
SEES
ABCT
INTODUCON
MATERIAL AND METODS
RESLTS
DISUSSON
ACKEN
REF
FIGURE LEGENDS
CHAPTER 1\1:
MUTALLY DEPENDEN RESPOE ELEMENTS IN THE CIS-REGULATORY
REGION OF THE NEUROTENINIEUROMEDIN N GENE INTEGRATE
ENVIRONMENTAL STIMUU IN PC12 CELLS.
ABCT
INTRODUCTION
RESULTS
DISUSON
EXPERIMENAL PROCEDURES
ACKEN
REF
FIGURE LEGENDS
CHAPTER IV:
NGF AND UTHIUM STRIKINGLY ACTIVATE PROMOTERS
CONTAINING MULTIPLE AP-1 SITES: IMPUCATIONS FOR
NEUROTESINIEUROMEDIN N PROMOTER FUNCTION. 108
ABCT
RESULTS AND DISCUSSIOO
109
110ACEN
REF
114
115
FIGURE LEGENDS 117
CHAPTER V:
DISUSIOO 124
CHAPTER VI
REFERENCES (CHAPTER I AND V) 139
APPENDIX A:
ADDITIOOAL SEQUENCE DATA
158
APPENDIX B:
TRASIENT TRAFECTION ASSYS
165
XlI
LIST OF FIGURES
CHAPTER II:
Figure 1: Structure of rat NT/N gene and sequencing strategy.
Figure 2: Sequence of the rat NT/N precursor gene and corresponding
sequences of bovine hypothalamus and canine intestinal
cDNAs.
Figure 3: Comparison of the predicted NTln precursor sequences form
rat, cow and do.
Figure 4: Determination of transcription initiation site.
Figure 5: RNA blot analysis.
CHAPTER II:
Figure 1: Transient transfection analysis of 5' deletion clones.
Figure 2: Increases in CAT activity are accmpanied by similar increases
in levels of accurately initiated fusion gene transcripts.
Figure 3: Synergistic induction of transiently expressed fusion gene
constructs. 100
Figure 4: The NT/N gene control region functions in either orientation
upstream of a heterologous promoter. 102
Figure 5: Mutational analysis of the NTIN promoter. 104
Figure 6: Expression in RAT2 fibroblasts and GH3 pituitary cells. 106
CHAPTER IV:
Figure 1: Uthium and NGF selectively activate promoters containing
multiple AP-1 sequences. 117
Figure 2: NGF and lithium potentiate forskolin- induced activation of
promters containing single and multiple CREs.
Figure 3: Activation of NT/N promoter by a combination of inducers is
dependent on protein kinase A activity.
CHAR 
Figure1: Model for the transcriptional regulation of the NT/N gene.
APPENDIX A: (Unpublished NT/N Gene Sequence Data).
Figure 1: Structure of the rat NT/N gene and subcloned
fragments.
Figure 2a: Sequencing strategy for 1.8 kb Eco/Hindll fragment
containing 5' flanking sequence/exon 1/portion of intron 1. 161
Figure 2b: Sequencing strategy for 2.2 kb Hindill/Bgi II fragment
containing 2 kb of intron 2 and portion of exon 3.
Figure 3: Rat NT/N 5' flanking region, sequencing strategy.
Figure 4: Bovine hypothalamic NT/N cDNA.
APPENDIX B: (Transient Transfection Assays).
Figure 1 a: Electroporation effeciency as a function of voltage.
Figure 1 b: Electroporation effeciency as a function of capacitance.
Figure 2: Electroporation effeciency as a function of DNA concentration. 176
Figure 3: CAT activity as a function of time.
Figure 4: Luciferase assay as a function of DNA concentration.
Figure 5: Induction of CAT activity and luciferase activity as a function
of recovery time post-transfection.
Figure 6: Induction kinetics of CAT and luciferase activity.
Xl11
120
122
138
160
162
163
164
173
174
178
180
182
184
XIV
COLLABORATORS
CHAPTER II:
Bryant Bullock isolated and plaque purified the phage containing the rat NT/N
ge.
Sandra McNeil subconed exon three and four of the rat gene, and was involved in
the initial characterization and sequencing of those exons. Sandy also isolated a
phage containing at least 10 kb of additional NT/N gene 5' flanking sequences.
CHAPTER III:
Dr. Gary Johnson donated the PC12 cells and purified NGF.
Dr. Carter Bancroft donated the GH3 cells and the plasmid pPRLCAT.
Dr. Janet Stavnezer provided us with the original CAT vectors.
Dr. Steve Nordeen provided the luciferase vectors.
Gabriella Ellott provided expert technical assistance, especially with the
construction of many of the linker mutations and plasmid preperations.
CHAPTER IV:
Dr. Richard Goodman provided the plasm ids RSVt\E, 1xCRE, and 4xCRE.
Dr. Carsten Jonat provided the plasm ids pBLCAT4, 1 xAP- 1, and 5xAP-
Dr. John Wagner provided the A126-1B2 and parental PC12 lines.
INTRODUCTION
Overview. The development and function of the nervous system in higher
animals is largely influenced by extracellular stimuli (Black et aI. , 1987). The
effects of extracellular stimuli on neuronal cells range from gross morphological
changes to subtle modulation in the synthesis of neurotransmitters. Such
phenotypic plasticity often occurs at a fundamental level of neuronal function,
altered gene expression (Goelet et aI., 1986; Morgan and Curran, 1989). To
understand how the extracellular environment regulates specific changes in
neuronal gene expression I have examined the regulated expression of
neurotensin , a neuroendocrine peptide, in the rat PC12 pheochromocytoma cell
line.
In the nervous system, extracellular regulators of phenotypic plasticity are
often collectively referred to as "environmental stimuli" (Black et aI. , 1987;
Goodman , 1990). They include: (1) growth factors, (2) hormones, (3)
neuropeptides and neurotransmitters, and (4) pharmacological agents. A variety
of growth factors such as nerve growth factor (NGF), brain-derived growth
factor (BDGF), ciliary neurotrophic factor (CNTF), and the fibroblast growth
factors (aFGF and bFGF) influence the survival and differentiation of neuronal
cells (Barde, 1989). NGF, for instance, initiates a cascade of events which
culminates in neuronal differentiation (Greenberg et aI., 1985). Steroid
hormones influence the growth and metabolism of most cell types. In the brain
steroids may coordinately modulate neural physiology (Evans and Arriza, 1989).
Glucocorticoids, in particular, appear to be important during the differentiation
of the embryonic neural crest (Doupe et aI., 1985). Neuropeptides and the
classical neurotransmitters are prominent modulators of neural activity (Lynch
and Synder, 1986). For example, recent evidence suggests that neurotensin
either directly or indirectly mediates the stimulatory effects of ovarian steroids
on gonadotropin releasing hormone (GNRH) secretion in the preoptic nucleus of
the brain (Alexander et aI., 1989). Pharmacological agents, such as anti-
psychotic drugs, represent a class of non-physiological stimuli often
characterized for their behavioral effects. In total , both physiological and non-
physiological stimuli modulate neuronal development and function.
Combinatorial mechanisms, involving a small number of environmental stimuli,
may provide an efficient means of generating greater phenotypic diversity and
specificity in response to these stimuli.
Two classes of receptors receive and transduce the effects of environmental
stimuli , membrane-associated and intracellular receptors (Morgan and Curran,
1989). Membrane-associated receptors are typically coupled to signal
tranduction pathways which generate second messengers such as cAMP and
diacylglycerol, and these second messengers appear to activate phosphorylation
events involved in gene expression. Intracellular receptors, on the other hand,
exemplified by the steroid/thyroid hormone receptor superfamily, modulate gene
expression by a different mechanism. They couple extracellular signals directly
to specific gene expression in the nucleus. Detailed analysis of specific genes
targeted by environmental stimuli in neuronal cells could expand our
understanding of the molecular mechanisms underlying stimulus/response
coupling and neuronal plasticity.
Neural crest: a model for phenotypic plastic ty. The complex process of
neural crest cell development provides an interesting example of how
environmental stimuli can generate phenotypic diversity through changes in
specific gene expression. The neural crest is a transient structure originating on
the apical surface of the neural tube. During embryogenesis, neural crest
progenitor cells migrate to form the peripheral nervous system and several non-
neural cell types, including adrenal chromaffin cells (Bronner- Fraser and
Fraser, 1989). Grafting experiments in which quail neural crest cells were
transplanted to different axial positions in a chicken embryo have determined
that the developmental potential of a neural crest progenitor cell at a given axial
position is greater than its actual developmental fate (LeDouarin , 1980). More
recently, fluorescent dextran microinjection and immunohistochemistry
techniques have been used successfully to verify the multipotent nature of
emigrating and pre-migratory trunk neural crest cells (Bronner- Fraser and
Fraser, 1989). These types of experiments suggest that the various derivatives
of the neural crest arise from a series of transitions, including migration
proliferation , differentiation , survival, and commitment, each influenced by
environmental stimuli (Anderson 1989). Two such environmental
determinants, nerve growth factor (NGF) and glucocorticoids, are proposed to
play key antagonistic roles in the development of the major catecholamine-
containing neural crest-derivatives (sympathetic neurons, adrenal chromaffin
cells and small intensely-fluorescent cells) which together form the
sympathoadrenal sublineage (Unsicker et aI., 1978). Glucocorticoids,
synthesized and present in high concentrations in the adrenal gland, are
necessary for adrenal chromaffin differentiation , in vitro (Doupe et aI., 1985a;
1985b; Un sicker et aI. , 1978). NGF, normally expressed from target tissues
innervated by neurons, promotes phenotypic conversion to sympathetic neurons
(Greene and Shooter, 1980). The developmental fate and survival of
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sympathoadrenal progenitors may reflect the relative concentrations of NGF and
glucocorticoids that these cells become exposed to during or following their
migration (Anderson and Axel , 1986).
The antagonism between NGF and glucocorticoids during sympathoadrenal
differentiation is also evident at the level of specific gene expression. Expression
of several neural specific genes is extinguished during chromaffn cell
differentiation and enhanced upon NGF-induced phenotypic conversion (Anderson
and Axel, 1985). A number of NGF- inducible mRNAs have been identified, many
of which are regulated in a reciprocal manner by glucocorticoids (Halazonetis et
al. 1988; Leonard et aI., 1987; Levi et aI., 1985, ; Sabol and Higuchi, 1990).
Frequently, simultaneous treatment with both agents leads to an intermediate
level of expression (Federoff et aI., 1988; Stein et aI., 1988). Thus,
antagonisms between environmental determinants, like NGF and glucocorticoids,
illustrate a regulatory mechanism for the generation of phenotypic plasticity.
Cellular responses to envir tal st muli. A model proposed by Curran and
Morgan (1987) to distinguish between short-term and long-term cellular
responses to extracellular stimuli can be applied to neuronal plasticity (Curran
1987). These authors propose that short-term responses are typically rapid
and transcription- independent. They occur immediately following stimulation
take from milliseconds to minutes, and likely involve post-translational,
covalent modification of existing substrates. However, long-term responses
occur within hours or days, are transcription-dependent, and involve changes in
gene expression. Both types of responses to extracellular stimuli involve altered
second messenger activity. These second messengers either act directly to elicit
short-term responses or through transcription regulatory proteins, which
modulate the expression of other genes, to elicit long-term responses. Thus,
short-term responses may account for the the instantaneous release of the
contents of secretory vesicles from a synapse while long-term responses may
ocur following the sequential activation of sets of genes.
The cellular " immediate-early" genes are excellent candidates for modulators
of long-term responses (Sheng, 1990). This class of genes is rapidly
transcribed in response to different environmental stimuli in the absence of
protein synthesis (Curran and Morgan, 1985; Greenberg et aI. , 1985; Kruijer
et aI., 1984). Several protooncogenes, including c- fos and c-jun, are classified
as " immediate-early genes. Both c-fos and c-jun are members of a family of
functionally related nuclear phosphoproteins that form heterodimeric and
homodimeric complexes capable of binding a common DNA sequence, the AP-
site (Kouzarides and Ziff, 1988, Sassone-Corsi et aI., 1988). The presence of
functional AP- binding sites within many cellular and viral promoters,
including certain members of the " immediate-early" family, adds support to the
hypothesis that phenotypic plasticity results from sequential gene activation
(Angel et aI., 1988; Angel et aI. , 1987; Lee et aI., 1987). Furthermore,
evidence suggests that AP-1 binding proteins may be involved in the regulation of
growth and development of the nervous system. Messenger RNAs encoding
putative transcription factors, including c-fos, c-jun, jun- , and erg- , are
transiently induced in the rat brain following chemically- induced seizure
(Mprgan and Curran, 1989). Subsequent to this intense stimulation and the
appearance of c-fos and c-jun transcripts, a transient burst in enkephalin gene
expression occurs (Sonnenberg et aI. , 1989). In total, the temporal and cell-
specific expression of several members of the AP- family suggest that
differential combinatorial mechanisms may be involved in a programmed genetic
response to environmental stimuli (Bartel et aI. , 1989). This mechanism may
underlie the diversity and specificity of cellular responses to these signals.
As mentioned above, in response to certain stimuli "immediate-early" genes
are induced rapidly and transiently, independent of transcription. Later, genes
which require protein synthesis are induced, including c-myc, ornithine
decarboxylase, GAP-43, the neural-specific gene SCG10, and several
neurofiament subunit genes (Sheng, 1990). These genes, termed the late
response genes, may represent targets of the transcription factors encoded by
certain " immediate-early" genes. In the nervous system , important downstream
targets of these putative transcription factors might include genes involved in the
synthesis of neurotransmitters (Gizang-Ginsberg and Zift, 1990), and
neuropeptides, such as en kephalin (Comb et aI. , 1989; Sonnenberg et aI. , 1989)
and neurotensin.
Neurotensin. The thirteen amino acid peptide neurotensin (NT) was
originally isolated from extracts of the bovine hypothalamus based on its acute
hypotensive effects (vasodilation and decreased blood pressure) in anesthetized
rats (Carraway and Leeman , 1973; 1975). NT- immunoreactivity is distributed
throughout both neural and endocrine tissues (Reinecke, 1985). In the
mammalian gut, NT is most prominent throughout the distal portion of the small
intestine. In the central nervous system NT is widely distributed in the
forebrain and limbic system. The biological importance of NT is underscored by
the number of related peptides isolated from genetically distinct organisms
(Reinecke, 1985). This family of NT -related peptides possess common
carboxyl-terminal sequences essential for biological activity and receptor
binding.
Although the function of NT is unclear, evidence supports its role in several
different activities. In the digestive system, NT may perform a paracrine or
endocrine role in fat metabolism (Ferris et aI. , 1985). In the mammalian
central nervous system, NT may function as a neurotransmitter or
neuromodulator (Elliot and Nemeroff, 1986; Leeman and Carraway, 1982). The
observation that NT/N mRNA levels are induced in response to estrogen treatment
in ovariectomized rats lends support to the role of neurotensin in modulating the
pre-ovulatory surge in luteinizing hormone (Alexander et aI., 1989). Also,
considerable evidence supports a close functional association between NT and the
dopamine (DA) systems, probably through synaptic interactions (Reinecke,
1985). The distribution of these two candidate neurotransmitters overlap
considerably. Both NT and DA have been co-localized to subsets of
catecholamine-containing neurons and adrenal medullary cells (Hokfelt et aI.,
1984; Terenghi et aI. , 1983). Interestingly, in the clonal PC12 cell line, DA
synthesis is constituitive and NT synthesis is inducible (Tischler et aI., 1986;
Tischler et aI., 1982). The isolation of cloned cDNAs encoding a putative
precursor for both NT and a related six amino acid neuroendocrine peptide,
neuromedin N (N), has made possible molecular approaches to understanding the
biosynthesis of the peptide and the regulated expression of the gene which encodes
them (Dobner et aI., 1987).
Neurotensin ReQulation in PC12 Cells. The clonal pheochromocytoma PC12
cell line provides an excellent model system to study neuroendocrine gene
regulation in response to environmental stimuli since it can be stimulated to
synthesize and secrete a number of neuroendocrine peptides, including
neurotensin (Greene and Tischler , 1982). Previous work has shown that NT/N
gene expression is strictly dependent on simultaneous exposure to multiple
inducers in PC12 cells. Combinations of nerve growth factor (NGF),
dexamethasone (a synthetic glucocorticoid), and activators of adenylate cyclase
act synergistically to increase NT content and production in PC 12 cells (Tischler
et aI. , 1986). Individual inducers, or a combination of dexamethasone and
forskolin , had virtually no effect on NT content. Interestingly, after prolonged
exposure (24-48 hrs) NGF in combination with dexamethasone or forskolin
resulted in detectable NT peptide levels, suggesting that NGF faciltated the
actions of both dexamethasone and forskolin. When lithium ion, an agent wihich
inhibits NGF- inducible neurite outgrowth in PC12 cells, was included in
subsequent experiments an unanticipated observation was made: lithium ion
substituted for, and strongly potentiated, responses to combinations of the other
three inducers on both NT peptide and NT/N mRNA levels (Dobner et aI. , 1988).
However, similar to each of the other three inducers, lihium alone did not induce
NT/N gene expression.
Several observations suggest that the observed regulation of NT/N gene
expression in vitro reflects regulation in vivo. First. PC12 cells exhibit
similar phenotypic plasticity in response to NGF, glucocorticoids, and activators
of intracellular cAMP as their normal cellular counterpart. the adrenal
chromaffin cell (Tischler et aI., 1986). PC12 cells convert from an endocrine
phenotype resembling an adrenal chromaffn cell to that of a post-mitotic
sympathetic neuron in response to NGF (Greene and Tischler, 1976). The
phenotypic changes include the extension of long neurite- like processes,
increased electrical excitibility, and altered neurotransmitter synthesis (Greene
and Tischler, 1982). Glucocorticoids antagonize NGF-induced phenotypic
conversion in primary cultures of chromaffin cells (Doupe et aI., 1985a). This
antagonism is evident at the level of specific gene expression, in PC12 cells
(Stein et aI., 1988). Secondly, NT- immunoreactivity has been detected in the
adrenal medulla of a variety of mammals, including rats (Goedert et aI. , 1983;
Rokaus et aI., 1984), and in sympathetic ganglia (Terenghi , et aI. , 1983).
Lastly, all three regulators can be accunted for within the region of the adrenal
gland: glucocorticoids are synthesized in high concentrations in the adrenal gland;
hormone-mediated signal tranduction or innervation could increase intracellular
cAMP in both adrenal chromaffin cells or sympathetic neurons, alike (Walicke
and Patterson, 1981); and evidence suggests that the adrenal gland expresses
NGF (Harper et aI., 1976).
A review the mechanisms of action of each of the four inducers, NGF, cAMP,
dexamethasone, and lithium, on gene expression will provide the necessary
framework for discussion of the complex regulation of NT/N gene expression in
PC12 cells. Although the focus of the following section is on transcription, this
does not imply that the effects of each inducer are solely transcriptional.
However, experiments presented in this thesis argue that each of the four
environmental stimuli modulate NT/N gene expression at the transcriptional
level in PC12 cells.
1 1
Nerve Orowth factor. A continuous flow of information from the periphery to
the nervous system is apparent from the effects of NGF on the peripheral nervous
system. The development, maintenance, and survival of sympathetic and neural
crest-derived sensory neurons is absolutely dependent on the continuous supply
of NGF expressed from tissues targetted by the peripheral nervous system
(Greene and Shooter, 1980; Levi-Montalcini and Angelett, 1968; Theonen and
Barde, 1980).
In spite of the progress in our understanding of these biological effects of NGF
its mechanism of action remains unclear. Cloning the NGF receptor has not
provided further clues (Johnson et aI., 1986; Radeke et aI., 1987).
conspicious A TP binding site or homology with receptors possessing protein
kinase activity or GTP-binding properties were found in the cytoplasmic domain.
However, recent evidence has suggested a role for the ras oncogene proteins in
NGF signal transduction. The capacity of activated ras p21 to mimic NGF-
induced phenotypic differentiation (Bar-Sagi and Feramisco, 1985; Barbacid,
1987), and its resemblance to GTP-binding proteins, suggests that GTP-binding
proteins might couple NGF receptor to second messenger pathways. NGF
receptor-activated signal transduction may involve phosphorylation events
mediated by multiple second messenger pathways. Evidence suggests that the
cAMP and protein kinase C second messenger pathways are activated in response
to NGF (Contreras and Guroff, 1987; Cremins et aI., 1986; Koizumi et aL
1988). Furthermore, the partial purification of NGF-specific kinases suggested
that NGF action may involve distinct phosphorylation mechanisms (Rowland-
Gagne and Greene, 1990). However, no clear connection has been established
between any NGF-activated second messengers and the biological actions of NGF.
1 2
The rat PC12 cell line has been extensively characterized as a model of NGF-
induced neuronal differentiation (Greene and Tischler, 1982). Much of our
current knowledge of stimulus- transcription coupling has been achieved with
PC12 cells; most notably, the NGF-induced expression of a class of " immediate
early" genes, which include members of the AP- 1 family transcription factors
(Sheng, 1990). The rapid transcription of genes encoding AP-1 proteins by NGF
has led to the speculation that AP-1 complexes may be involved in NGF-induced
neuronal differentiation, specifically the activation of genes regulated by
promoters containing AP-1 binding sites. Two candidate genes regulated by AP-
binding sites are the neuropeptides proenkephalin (Sonnenberg et aI., 1989) and
neuropeptide Y (Gizang-Ginsberg and Ziff, 1990). Evidence presented in this
thesis suggests that the NT/N gene might also constitute a target of AP-1 mediated
transcription.
Cyclic A Cyclic AMP mediates the the intracellular response to a wide
variety of hormones and neurotransmitters (Sunderland, 1972). The cascade of
cAMP- induced phosphorylation events, following activation of adenylate cyclase,
modulate multiple cellular process, including transcription (Roesler et aI.
1988). Among the variety of viral and cellular genes which are regulated by
elevated levels of intracellular cAMP are several neuropeptide genes, including
somatostatin (Montminy et aI., 1986), vasoactive intestinal polypeptide
(Tsukada et aI., 1987), proenkephalin (Comb et aI., 1986), and the alpha
subunit of choriogonadotropin (Deutsch et aI., 1987).
Most cAMP-regulated genes contain a conserved sequence in the 5' flanking
region related to the palindromic octamer 5' TGACGTCA-3' (cAMP-responsive
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element; CRE) . The 17 bp vasoactive intestinal peptide (VIP) gene CREs,
containing two inverted copies of the 5' CGTCA-3' motif, are also active (Fink et
aI., 1988). However, the mere presence of an 8-bp CRE consensus or 5'
CGTCA-3' motif within a promoter may not be sufficient for function. Both the
bovine parathyroid hormone (PTH) gene, and rat glucogon gene contain aCRE
consensus, but are unresponsive to cAMP. Montminy et al. (1986) have shown
that a 10 bp oligonucleotide encompassing the somatostain CRE was unable to
confer cAMP-regulation to the SV40 minimal promoter linked 
chloramphenicol acetyltransferase (CAT) reporter gene while a 32 bp sequence
was cAMP-responsive. Relevant to these observations, Deutsch et al. (1988)
have demonstrated that sequences flanking the related consensus sequences of
CREs and AP- 1 binding sites markedly influence their respective responses to
cAMP and phorbol esters when these sites are fused to the human a gonadotropin
minimal promoter; although, no clear flanking sequence consensus was derived.
Interconversion of CRE and AP-1 sites by the insertion or deletion of a single
base can dissociate the functional properties of these two elements. The non-
responsive PTH gene CRE was converted to a phorbol ester- inducible AP-
consensus binding site by deleting a single base. In certain contexts AP-
consensus sequences mediate responses to both cAMP and phorbol esters. The
dual and sometimes synergistic response to combinations of cAMP and phorbol
esters mediated by AP- 1 binding sites illustrates the potentially complex
interactions between two parallel signal transduction mechanisms at the level of
transcription (Deutsch et aI., 1988; Hoeffler et aI., 1989).
prominent 43 kd nuclear CRE-binding protein , CREB, has been
characterized and cloned from PC12 cells and brain tissue, (Hoeffler et aI.,
1988; Montminy and Bilezikjian, 1987). Phosphorylation of CREB at a specific
serine residue (SER-133) by cAMP-dependent protein kinase A is proposed to
activate CREB-mediated transcription , but does not increase its affinity for DNA
(Bokar et aI., 1988; Delegeane et aI., 1987; Gonzalez and Montminy, 1989),
suggesting that the CREB protein may be constituitively bound to the CRE
(Roesler et aI., 1988) A cluster of consensus phosphorylation sites for protein
kinase C, protein kinase A and casein kinase II between postions 130 and 133 in
the predicted CREB protein sequence has implicated multiple phosphorylation
pathways in the regulation of CREB activity. Indeed, phosphorylation of CREB by
protein kinase C stimulates dimerization, but does not activate transcription, in
vitro (Yamamoto et aI., 1988). These phosphorylation sites could coordinately
regulate CREB activity. Synergy between activators of protein kinase A and
protein kinase C support such a mechanism (Deutsch et aI., 1988; Hoeffler et
aI., 1989). However, the existence of other structurally-related CRE-binding
proteins offers an additional means of generating diversity in response to cAMP
(Hai et aI., 1988; Hai et aI., 1989). Interestingly, only certain members of
this family can form heterodimers. Furthermore, those heterodimers which od
form , differ in their precise interactions with a CRE consensus sequence.
Lithium ion. Lithium has profound effects on human behavior and early
embryogensis (Berridge et aI., 1989). The mechanism responsible for these
actions remains unknown, although intensively investigated. Common to many
hypotheses concerning lithium s actions are alterations in receptor-mediated
signal transduction (Avissar et aI. , 1988, Berridge et aI. , 1982; Newman and
Belmaker, 1987). The inositol depletion hypothesis, in particular, appears to
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best address the neural and developmental specificity of lithium s actions
(Berridge et aI., 1989). It argues that lihium inhibits particular phosphatases
involved in the dephosphorylation of inositol mono- and polyphosphates which
are necessary for the synthesis and recycling of inositol lipids. Low-
permeability of the blood-brain barrier to dietary inositol and the absence of a
circulatory system (in the developing embryo) presumably accounts for its
neural specificity. Thus, cells sequestered from plasma inositol are particularly
sensitive to lithium action. This model also accounts for the time-dependent and
stimulus-dependent physiological actions of lithium. As an uncompetitive
inhibitor binding to the enzyme-substrate complex , lithium would exert a lower
effect on less-active cells than hyper-stimulated cells. Therefore, in the central
nervous system lithium could drive hyperactive receptors into a normal
operating range, while during embryogenesis lithium could respecify the normal
gradient of phoshoinositol turnover in the dorsal-vental axis. Support for the
phospho inositol (PI) signallng pathway in neural signallng and development
stems from the ability to rescue lithium- induced dorsalized embryos 
injections of myo- inositol into the ventral pole (Busa and Gimlich, 1989).
The logical extension of these alterations in signal transduction are changes in
gene expression. Oddly, litte attention has been directed toward understanding
lithium effects on gene expression. As a consequence of perturbed
phosphoinositol- and cAMP-mediated signal transduction , lithium could modulate
environmentally-induced changes in gene expression negatively. However
Dobner et al. (1988) have shown that lithium potentiates NT IN gene expression
markedly. One possible explanation might be was that lithium both dampens and
enhances responses dependent on the PI turnover. For example, the
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phosphoinositol-mediated contractile response to the muscarinic receptor
agonist, carbachol, is potentiated by lithium treatment (Menkes et aI. , 1986).
Furthermore, lithium treatment results in the accumulation of diacylglycerol
(DAG) in a rat pituitary tumor cell line (Drummond and Raeburn, 1984) which
could activate protein kinase C (Nishizuka, 1984) and enhance adenylate cyclase
activity (Otte et aI., 1989). Evidence strongly suggests that protein kinase C-
dependent mechanisms include the AP- 1-mediated activation of transcription
(Lee et aI., 1987) and the potential modification of CREB (Yamamoto et aI.,
1988). Experimental evidence presented in this thesis indicates that lithium
activates specific gene transcription through promoters containing AP- 1 binding
sites and potentiates forskolin- induced CRE-mediated transcription.
Glucocorticoids. The effects of glucocorticoids on the differentiation of neural
crest progenitors are well characterized (Doupe et aI., 1985a; 1985b).
However, the modulating role of steroid hormones in the central nervous system,
while aggressively studied, is far from understood. The recent observation that
estrogen induces NT/N mRNA levels in the preoptic nucleus in brains of
ovariectomized rats lends support to the specific regional effects of steroids in
the brain (Alexander et aI., 1989). A combination of structural, biochemical,
and genetic analyses of the steroid receptors and hormone-responsive genes has
led to a more detailed understanding of the molecular mechanisms of the steroid
response and a unifying hypothesis for receptor structure and hormone action
(Beato, 1989; Evans and Arriza, 1989).
Structural similarities between the steroid and thryroid hormone receptors
support the existence of a steroid/thyroid hormone receptor superfamily of
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transcriptional regulators (Evans, 1988). Based on structural and functional
characteristics, these receptors can be divided into two groups (Beato, 1989).
One group contains the glucocorticoid, progesterone, androgen, and
mineralcorticoid receptors. The other group contains the estrogen, thyroid
hormone, retinoic acid , and vitamin D3 receptors. The typical receptor is
composed of a variable N-terminal domain, a short highly-conserved and
cysteine-rich central domain, and a moderately-conserved C-terminal domain.
Extensive mutational analyses of receptor cDNAs suggest that: (1) the C-
terminal domain is functionally complex, mediating hormone binding, nuclear
translocation, dimerization, and the activation of transcription (trans-
activation); (2) the central domain mediates DNA binding; and (3) the N-
terminal domain co-modulates transactivation with the C-terminal domain.
Based on those and numerous other studies, steroid-regulated gene expression
has been divided into several loosely defined steps. Basically, upon binding of
steroid to its cytoplasmic receptor, an allosteric activation (termed
transformation ) of the receptor is proposed to occur, possibly involving the
dissociation of attendant heat shock proteins from the receptor, thereby enabling
hormone-receptor complexes to localize to the nucleus and interact specifically
with DNA (O'Malley, 1990). In this manner, the steroid receptor functions as a
hormone-dependent transcription factor.
Sequence-specific interactions between the steroid-hormone receptor
complex and DNA have been proposed to accunt for both positive and negative
effects on transcription (Ackerblom et aI., 1988; Sakai et aI., 1989; Yamamoto,
1985). Steroid-responsive elements (SREs) are often found clustered with
binding sites for other transcription factors in several promoters (Schule et aI.,
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1988). In general, synergy between these elements appears to be inversely
related to the individual strength of each SRE. For example, the proximal
glucocorticoid-responsive element (GRE) of the tryptophan oxygenase gene is
weakly active in the absence of a CACCC-box, a common transcription factor
- -
binding site (Schule et aI., 1988). In addition, mutation of the NF I site within
the MMTV enhancer results in severely diminished glucocorticoid responsiveness
(Strahle et aI., 1988). Thus, certain steroid-responsive elements are
functionally dependent on other cis-regulatory elements. The NT/N promoter
characterized in this thesis, is an example of a complex cis-regulatory region
composed of functionally interdependent elements.
Experimental approach. To begin elucidating the molecular mechanisms of
synergy between environmental stimuli which induce NT/N gene expression in
PC12 cells, I have characterized the rat NT/N gene. Chapter II of this thesis
descibes the NT/N gene, its structure, tissue-specific regulation, and sequence
evolution. In Appendix A a considerable amount of unpublished sequence
information is provided, including the sequencing strategy for the bovine
hypothalamic cDNA, intron sequences, and 1.4 kb of 5 flanking sequence.
Appendix B reviews the experimental approach to establishing a transient
transfection methodology for analyzing NT/N gene cis-regulatory sequences in
PC12 cells. Chapter III reports the analysis of mutually dependent elements in
the NT/N gene cis-regulatory region which are involved in the synergistic
responses to cAMP , dexamethasone, NGF , and lithium. The experiments of
Chapter IV investigate the mechanism of synergy between three inducers (NGF
forskolin, and lithium) on two types of elements present in the NT/N
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transcriptional control region , AP-1 and cAMP-responsive elements. Chapter V
summarizes the results of the previous chapters and proposes a model for the
complex transcriptional regulation of the NT/N gene in PC12 cells.
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THE RAT GENE ENCODING NEUROTENSIN AND NEUROMEDIN N:
STRUCTURE, TISSUE-SPECIFIC EXPRESSION AND
EVOLUTION OF EXON SEQUENCES
Kislauskis, E., Bullock , B., McNeil , S. and Dobner, P.R. (1988) J. BioI. Chem.
263, 4963-4968.
ABSTRACT
Recombinant DNA clones encoding the neurotensin/neuromedin N precursor
protein have been isolated from both bovine hypothalamus cDNA and rat genomic
libraries using a heterologous canine cDNA probe. Nucleotide sequence analysis
of these clones and comparison with the previously determined canine sequence
has revealed that 76% of the amino acid residues are conserved in all three
species. The protein precursor sequences predicted from bovine hypothalamus
and canine intestine cDNA clones vary at only nine of 170 amino acid residues
suggesting that within a species identical precursors are synthesized in both the
central nervous system and intestine. The rat gene spans approximately 10.2 kb
and is divided into four exons by three introns. The neurotensin and neuromedin
N coding domains are tandemly positioned on exon four. RNA blot analysis has
revealed that the rat gene is transcribed to yield two distinct mRNAs. 1.0 and 1.
kb in size, in all gastrointestinal and all neural tissues examined except the
cerebellum. There is a striking variation in the relative levels of these two
mRNAs between brain and intestine. The smaller 1.0 kb mRNA greatly
predominates in intestine while both mRNA species are nearly equally abundant
in hypothalamus, brain stem, and cortex. Sequence comparisons and RNA blot
analysis indicate that these two mRNAs result from the differential utilization of
two consensus poly(A) addition signals and differ in the extent of their 3'
untranslated regions. The relative combined levels of the two mRNAs in various
brain and intestine regions correspond roughly with the relative levels of
immunologically detectable neurotensin except in the cerebral cortex where
mRNA levels are 6 times higher than anticipated.
INTRODUCTION
Neurotensin (NT) is a member of a family of structurally related peptides
which cause contraction of smooth muscle and, when injected into the periphery
of anesthetized rats, an acute hypotensive response. The carboxy-terminal
portion of NT is the major determinant of biological acitivity (1) and is the most
conserved region of the different family members. The frog skin peptide,
xenopsin (2), shares four of five carboxy-terminal amino acid residues with NT.
Similarly, the four carboxy-terminal amino acids of NT and a six amino acid
peptide isolated from porcine spinal cord, neuromedin N, are identical (3).
Recently, we have determined the primary structure of a 170 amino acid
precursor protein which encodes both NT and neuromedin N by sequencing cDNA
clones derived from the canine intestine (4).
NT was first isolated from bovine hypothalamus (5) and is likely to serve as
a neurotransmitter or neuromodulator in the central nervous system (6). The
development of a radioimmunoassay for NT led to the discovery of NT in the
gastrointestinal tract ( 7) where it may be involved in the regulation of fat
metabolism (8). Discrete NT-containing endocrine cells are found dispersed
throughout the intestinal mucosa, most prominently in the distal small intestine
(9). NT has also been detected in the adrenal medulla of a variety of mammals
(10). In cats, a specific subpopulation of noradrenaline-containing chromaffin
cells also contain NT (11). Interestingly, the rat pheochromocytoma PC12 cell
line, which displays some of the phenotypic characteristics of adrenal chromaffin
cells, can be induced to produce high levels of NT immunoreactive material by
combinations of hormones (12, 13). NT content and production are increased up
to GOO-fold by the combined action of nerve growth factor (NGF),
dexamethasone, and activators of adenyl cyclase. The induction is highly
cooperative with NGF exerting primarily a permissive effect. This is exciting in
view of the importance of NGF as a survival and differentiation factor affecting
cells which migrate from the neural crest during development (14). PC12 cells
are thought to be representative of pleuripotent neural crest cells and
differentiate along a sympathetic neuronal pathway in response to NGF (15).
The isolation of cDNA clones encoding NT has made possible molecular
approaches to understanding the biosynthesis of the peptide and the regulation of
the gene which encodes it. To examine these questions in tractable experimental
models, we have isolated and characterized the rat gene encoding the
NT/neuromedin N (NT/N) precursor and examined its tissue-specific
expression. We also report that it is likely that an identical NT/N precursor is
synthesized in the gut and central nervous system.
MATERIALS AND METHODS
Materials. Avian myeloblastosis virus reverse transcriptase, Life Sciences
(St. Petersburg, FL); restriction and other enzymes, Boehringer Mannheim and
New England Biolabs; 32P- labeled nucleotides, Amersham; deoxy and dideoxy
nucleotides, PL Biochemical.
Construction of recombinant libraries. DNA was isolated from rat testes,
partially digested with Sau 3a, and size-fractionated on sucrose gradients.
Digestion products 15-20 kb in size were ligated with Sam HI digested IEMBL4
phage arms, and packaged in vitro as described (16). A cDNA library was
constructed from poly(A)+ RNA isolated from bovine hypothalamus in Igt11 as
described (4).
ScreeninQ procedu es. Escherichia coli (K802 or Y1088) were infected
with recombinant phage and plated onto 15 cm bacterial plates at a density of
20,000-30,000 placques per plate. The Eco RI insert of a full-length canine
neurotensin precursor cDNA (4) was 32P- labeled by nick translation and used
to screen recombinants as described (16). Hybridization was performed in 5 X
NaCI/sodium citrate (1 X NaCVsodium citrate = 0. 15 M NaCI/0.015 M sodium
citrate, pH 7), 10 X Denhardt's solution (1 X Denhardt' solution = bovine
serum albumin , polyvinylpyrrolidone, and Ficoll all at 0. mg/ml), 50 
sodium phosphate buffer (pH 7), 0.5% sodium dodecyl sulfate at 60 C and the
fiters were washed in several changes of 2 X NaCI/sodium citrate, 0. 1 % sodium
dodecyl sulfate at room temperature followed by a wash in the same solution at
C. Positively hybridizing bacteriophage were placque purified and I DNA was
prepared as described (16).
DNA sequence analysis. Restriction fragments of rat genomic clones
encompassing exons were identified by Southern blotting using a 32P- labeled
canine neurotensin precursor cDNA probe and subcloned into either pGEM4
(Promega) or pUC12 (17). Various defined fragments were subcloned into
M13mp10 or mp11 (17) and sequenced by the dideoxy method (18).
RNA analysis. RNA was extracted from various tissues by the guanidine
thiocyanate procedure (19) and poly(A)+ RNA was selected by passage over oligo
dT cellulose (20). RNA blot analysis, and nuclease protection experiments were
performed as described (21 , 22). For primer extension , 32P- labeled DNA
primer (100,000 cpm) was hybridized to RNA in 0.1 M NaCI , 20 mM Tris- HCI
(pH7.9), 0.1 mM EDT A for 10 hr at C. An equal volume of a solution
containing 80 mM Tris-HCI (pH 7), 10 mM MgCI2 , 4 mM each of dGTP , dCTP
dA TP , TIP and 10 units of reverse transcriptase were added on ice. The reactions
were incubated at 37 C for 30 min and the products were analyzed as described
(22). Uniformly labeled single-stranded probes were synthesized using an Eco
RI/Hinf I fragment of rNT19 subcloned in M13mp10. The probes used for
primer extension and nuclease protection were generated by cleavage with Sst I
and Eco RI , respectively, followed by isolation of the labeled strand on 6%
acrylamide, 7 M urea gels.
RESUL TS
Screenino of Libraries. Recently, we have demonstrated using a canine NT/N
cDNA probe that different sized NT/N mRNAs are expressed in bovine
hypothalamus and canine intestine (4). A 1.5 kb poly(A)+ RNA is detected in
bovine hypothalamus while a 1.0 kb poly(A)+ RNA is detected in the canine
intestine. These results opened the possibility that these mRNAs encoded
different precursor proteins specific to either neural or gastrointestinal tissues.
They also suggested that the canine cDNA probe could be used to isolate
corresponding sequences from other mammalian species. Southern blot analysis
of dog, rat, and human genomic DNA revealed that an unique gene was identified by
the canine NT/N probe in each case (data not shown). To examine the structure
of the larger 1.5 kb RNA detected in bovine hypothalamus and to characterize the
rat NT/N gene, we screened a Igt11 cDNA library derived from bovine
hypothalamic poly(A)+ RNA and a rat genomic library constructed using IEMBL4
with a 32P- labeled canine NT/N cDNA probe.
Screening of approximately 240,000 plaques from the bovine hypothalamus
cDNA library resulted in the identification of fourteen hybridization-positive
clones. Based on preliminary restriction analysis, two of these (bhNT3 and
bhNT12) were selected for detailed analysis. Approximately 360,000
independent rat genomic recombinants were screened resulting in the isolation of
three hybridization-positive clones. Two of these were nearly identical (rNT18
and rNT19) while the third (rNT23) overlapped throughout half of the cloned
sequences. Southern blot analysis using the canine cDNA probe indicated that
rNT18 and rNT19 contained the entire rat NT/N precursor gene and rNT19 was
chosen for detailed analysis.
EQuivalent Protein Precursors in Hypothalamus and Intestine. The composite
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structure of the bovine hypothalamus cDNA clones is depicted in Fig. 1 A along
with the structures of the rat gene and previously described canine cDNA clones.
The complete cDNA sequences and comparable exon sequences from the rat gene
are presented in Fig. 2. The NT/N protein precursor predicted from the bovine
hypothalamus cDNA sequence is nearly identical to that determined previously
from canine intestine cDNAs. The general features of the precursor are the same
with the neuromedin Nand neurotensin coding domains located in tandem near the
carboxy terminus of a 170 amino acid protein , bounded and separated by Lys-Arg
basic amino acid pairs. There is also considerable similarity in the untranslated
regions; however, the 3' untranslated region of the bovine sequence extends 402
bases beyond the comparable region of the canine sequence. In addition to a
consensus poly(A) signal common to the two cDNA sequences, the bovine sequence
contains a consensus signal near the end of the extended region.
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Structure of the Neurotensin/Neuromedin N Gene. Restriction fragments of
rNT19 harboring exons were identified by Southern blot analysis and subcloned
for sequence analysis. Nucleotide sequences were determined by the dideoxy
method using the strategy shown in Fig. 1 B. The gene spans approximately 10.
kb of DNA and comparison with heterologous canine and bovine cDNAs has
revealed the positions of three intervening sequences which divide the mRNA
sequence into four exons. The sequences at the junctions between exons and
introns conform to consensus splice donor and acceptor sequences (23). Exon
one encodes the putative signal peptide; however, the remaining divisions of the
gene do not clearly demarcate functional domains. The neurotensin and
neuromedin N coing domains are both locted in tandem on exon four.
Evolution of Exon SeQuences. The predicted precusor protein sequences from
dog, cow, and rat are compared in Fig. 3. The canine and bovine sequences are
closely conserved displaying 95% amino acid identities. The rat sequence is ""1
more divergent as judged by comparison with either the dog or cow sequence with
77 and 78% amino acid identities, respectively. However, most of the
substitutions between species are conservative (as defined by the Dayhoff
PAM250 matrix (24)).
At the nucleotide level , the sequence conservation in the coding region is
roughly the same as that at the amino acid level. In addition , there is substantial
homology in the untranslated regions. The 5' and 3' untranslated regions of the
cow and dog are closely related with 92 and 93% of the comparable positions
conserved, respectively. The rat gene untranslated sequences are more divergent
and substantial gaps must be introduced to obtain optimal alignment. However
sequences strikingly similar to both the proximal portion of the 3' untranslated
region shared between the dog and cow cDNAs and the extended portion contained
only in the cow cDNA are contiguous on exon four of the rat gene. Two consensus
poly(A) addition signals are present in both the rat gene and bovine cDNA
seuencs.
Expression of the Rat Neurotensin/Neuromedin N Gene. To define the start
point of transcription, primer extension and nuclease protection experiments
were performed using RNA isolated from both gastrointestinal and neuronal
tissues (Fig. 4). Hybridization of a single-stranded probe extending from exon
one through to the 5' end of the sequences contained in rNT19 with poly(A)+ RNA
from either tissue source and subsequent digestion with mung bean nuclease
resulted in a group of closely spaced protected fragments (Fig. 4A); the two most
prominent bands map to positions 152 and 154 of the rat NT/N gene.
Hybridization of a single stranded primer (see Fig. 4C) with RNA from either
tissue source and subsequent extension with reverse transcriptase resulted in
the formation of two prominent extension products which map to positions 154
and 157 (Fig. 4B). Thus, the cap site is either at or near position 154. This
assignment is supported by the occurrence of a liT AT A" homology (positions 125-
132) 29 base pairs upstream of the assigned cap site. Also noteworthy, is a
sequence beginning at position 99 which bears a striking resemblence to the
cAMP response element previously defined for the rat somatostatin (25) and
human preproenkephalin (26) genes. In addition, two 21 base pair imperfect
direct repeats are encountered upstream of the liT AT A" homology beginning at
positions 27 and 59.
To examine the tissue specificity of rat NT/N gene expression , poly(A)+ RNA
was prepared from various tissues and examined by RNA blot analysis (Fig. 5).
Using a 32P- labeled single-stranded probe corresponding to the coding region
and part of the 3' untranslated region of exon four (rNTB61, Fig. 5C), two
prominent bands of approximately 1.0 and 1.5 kb were observed in all neural
tissues except the cerebellum (Fig. 5A). In gastrointestinal tissues, the 1.0 kb
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RNA is clearly identified but the 1.5 kb RNA is only faintly visible (Fig. SA, most
evident in lane 7) suggesting that the ratio of these two mRNAs may vary in a
tissue-specific manner (see Discussion).
Comparison of the rat gene sequence with the bovine and canine cDNA
sequences suggested that the two mRNAs might arise as a result of the utilization
of both of the poly (A) addition signals encountered in exon four of the rat gene.
To test this possibility, a 32P- labeled single-stranded probe (3' UT- , Fig. SC)
corresponding to the distal portion of the 3' untranslated region (as defined by
the bovine cDNA sequence) was used to probe the same RNA blot (Fig. SB). This
probe identifies only one mRNA species corresponding to the upper band
identified by the coding region probe. This band is present in all gastrointestinal
and neuronal tissues with the exception of the cerebellum. As with the previous
probe, there is no detectable NT/N mRNA expressed in testis, liver, or kidney.
These results strongly support the contention that the two NT/N mRNAs are the
result of the utilization of two different poly(A) addition signals.
DISCUSSION
We have previously characterized cDNA clones derived from the canine
intestinal mucosa which encode neurotensin and neuromedin N (4). By screening
rat genomic and bovine hypothalamic cDNA libraries with the canine probe, we
have isolated the rat NT/N gene and bovine hypothalamic NT/N cDNA clones.
Nucleotide sequence analysis has revealed that the general features of the
predicted NT/N precursor are the same in all three species. The cow and dog
sequences are closely conserved differing at only nine of 170 amino acid
residues. The rat sequence is missing one of the two tandem methionine codons
which begin the cow and dog sequences and is more divergent. The near identity of
the precursor predicted from either canine intestine or bovine hypothalamus
cDNA clones indicates that both NT and neuromedin N are processed from an
equivalent precursor in the gut and the nervous system.
The rat NT/N gene coding region is divided into four exons by three introns as
revealed by comparison with the two heterologous cDNA sequences. Although exon
one encodes only the putative signal peptide (amino acids 1-23) with the
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aspartate codon split by intron one probably comprising part of the cleavage
signal (27), the positions of the remaining two introns do not divide the gene into
obvious functional domains. The remaining exons encode amino acids 24-
(exon two), 45-119 (exon three), 120-169 (exon four). The NT and
neuromedin N coding domains are located in tandem near the carboxy terminus of
the predicted precursor on exon four. This feature of the gene in addition to the
fact that we have thus far isolated only cDNAs which encode both NT and
neuromedin N indicates that distinct mRNAs encoding only NT or neuromedin 
cannot be generated by alternative splicing mechanisms.
Comparison of the complete NT/N precursor protein sequence from dog, cow,
and rat has revealed a tight evolutionary conservation. Of 169 comparable
positions, 76% are identical in all three species and most of the substitutions are
conservative. Based on our data and previously reported sequences for bovine
neurotensin (28) and porcine neuromedin N (3), the sequences of these two
peptides appears to be invariant among mammals. The high degree of
conservation of the entire precursor could reflect structural requirements for
appropriate precursor processing to yield the biologically active peptides.
Alternatively, the precursor might be processed to yield biologically acitve
peptides other than neurotensin and neuromedin N which are subject to high
selective constraints. The precursor sequence is much more highly conserved
between dog and cow (95%) than between either of these species and rat (77 and
78%, respectively). This could be due to the higher rate of nucleotide
substitution which has been postulated for rodents (29, 30).
In addition to the close conservation of the coding region between the three
species, there is also substantial similarity in the untranslated regions (see Fig.
2). Comparison of the 3' untranslated regions of the canine and bovine sequences
has revealed that, in addition to a common proximal region spanning
approximately 200 nucleotides which is 90% identical, the bovine sequence
extends approximately 400 nucleotides further where a second consensus
poly(A) addition signal is encountered. This extended 3' untranslated region
accounts nicely for the difference in the sizes of canine intestine and bovine
hypothalamus NT/N mRNAs we have observed previously (4). The composite
bovine cDNA sequence is 1166 nucleotides in length and, allowing for a 150-200
base poly(A) tail, the mRNA size of 1316-1366 is similar to our previous
estimate of 1.5 kb based on RNA blot analysis. Comparison of the bovine cDNA
with the rat gene sequence reveals sequences strikingly similar to both the
proximal part of the 3' untranslated region (as defined by dog and cow cDNAs)
and the distal part (contained only in the bovine cDNA). These sequences are
contiguous on exon four of the rat gene.
We have examined the tissue specificity of rat NT/N gene expression by RNA
blot analysis using probes derived from exon sequences of the rat gene. Using a
probe containing the coding and proximal part of the 3' untranslated region of
exon four, two poly(A)+ RNAs were detected in all gastrointestinal and neuronal
tissues examined with the exception of cerebellum (Fig. SA). Quantitation of the
two bands by scanning densitometry (data not shown) revealed that the ratio of
the level of the 1.5 kb to the 1.0 kb species ranges from 1. 1 in the cerebral
cortex to 0.8 in hypothalamus and brainstem. This ratio is drastically altered in
gastrointestinal tissues where the 1.0 kb mRNA is at least 10 times more
abundant than the 1.5 kb mRNA. The sizes of these two mRNAs (1.0 and 1.5 kb)
correspond roughly to the sizes of the canine intestine (1.0 kb; previously
reported smaller RNA species have not been observed in subsequent experiments;
Diane L. Barber and P.R. D., unpublished observations) and bovine hypothalamus
(1.5 kb) NT/N mRNAs (4). Reprobing the same blot with a probe corresponding
to only the distal portion of the 3' untranslated region (Fig. 5B) resulted in the
identification of only the 1.5 kb mRNA species, strongly indicating that the
difference between the two mRNAs is in the extent of their 3' untranslated
regions. Thus, in the rat, both of the mRNA types defined by heterologous cDNAs
are produced apparently by the utilization of different poly(A) addition signals.
Furthermore, the proximal site is highly favored in intestinal tissues. Whether
or not the inclusion or exclusion of the distal 3' untranslated region has any
functional consequence remains to be determined.
The relative levels of NT/N mRNA (quantitated by scanning several different
exposures of the blot shown in Fig. 5A and summing the values obtained for both
the 1.0 and 1.5 kb bands, data not shown) are roughly equivalent to the relative
levels of NT in these tissues as determined by radioimmunoassay (7). For
instance, the level of NT/N mRNA in the hypothalamus is 5.7 times greater than
in brainstem which is similar to the 4. fold difference in NT content between
these two tissues. However, although the NT content of the hypothalamus is 30
times that of the cortex , the NT/N mRNA levels in cortex are only 5-fold lower
than in hypothalamus. This striking difference opens the possibility that the
NT/N protein precursor is differentially processed in cortex and hypothalamus
resulting in the disparity between the levels of immunologically detected NT and
the relative NT/N mRNA levels. The best example of such tissue-specific
processing is the differential processing of the proopiomelanocorticotropin
precursor in the anterior and intermediate lobes of the pituitary (31).
We have mapped the rat NT/N gene cap site to position 154 by both primer
extension and nuclease protection experiments using RNA isolated from both
intestine and brain. As is the case for many eukaryotic genes transcribed by RNA
polymerase II (32), a "TAT A" homology is encountered starting 29 base pairs
upstream of the cap site. In addition, a sequence matching the previously defined
cAMP response element (25, 26) at seven of eight positions is located between
positions 103 and 110 of the rat gene and is immediately preceded by another
half repeat of this palindromic sequence (99- 102). This cAMP response
element could be involved in the control of NT levels in the rat PC12 cell line by
combinations of nerve growth factor, dexamethasone, and activators of adenylate
cyclase (13). The isolation of the rat NT/N gene wil enable investigations of the
molecular mechanisms underlying this complex synergistic control.
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Figure 1. Structure of rat neurotensin/neuromedin N gene and sequencing
strategy. (A) The structure of rNT19 isolated from a rat genomic recombinant
library. In the rat gene, black boxes denote exons and thin lines denote either
introns or flanking sequences. Eco RI (E) and Hind III (H) restriction sites are
indicated. The structure of the gene is projected onto schematic representations
of cow and dog NT/N cDNA clones. Boxes represent coding sequences and known
functional domains are indicated by diamonds, signal sequence; vertical lines,
neuromedin N- like; diagonal lines, neuromedin N; black neurotensin; open,
regions of unknown function. (B) Regions of rNT19 corresponding to exons
were id.entified by Southern blot analysis and subcloned into plasmid vectors.
Exon sequences were determined by the dideoxymethod using the strategy
depicted. Exon sequences are indicated by either black boxes (coding) or open
(untranslated) boxes; other sequences are indicated by a thin line.
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Figure 2. Sequence of the rat neurotensin/neuromedin N precursor gene and
corresponding sequences of bovine hypothalamus and canine intestine cDNAs. Rat
gene sequences were determined by the dideoxy method using the strategy depicted
in Fig. 1 Bovine hypothalamus cDNA sequences were compiled from two
independent recombinants (bhNT3 and bhNT12) by strategies similar to those
used previously to determine the canine intestine cDNA sequence (4). The canine
sequence has been extended using data compiled from two recombinants not
previously reported (ciNT11 E and ciNT5B). The numbering of the rat sequence
begins at the first nucleotide of the Sau 3A cloning site and does not include
intervening sequences which have not been completely determined. The bovine
(middle) and canine (lower) cDNA sequences starting at positions 200 and 207
respectively, are presented below the rat sequence. The positions of the three
intervening sequences are indicated by arrows and the conserved consensus splice
donor and acceptor sequences are shown. The cap site (arrowhead), liT A T A"
homology (bold underline), and a sequence resembling a cAMP response element
(bold lines above and below) are indicated. The first and last nucleotides of the
cDNA sequences are indicated by an asterick and a plus sign , respectively. The
positions of two direct 21 base pair repeats and of two poly(A) addition signals
are indicated by thin underlines. The predicted amino acid sequence of the rat
NT/N precursor protein is shown above the rat DNA sequence. Differences
between the rat and either cow, or dog cDNA sequences are indicated with gaps
necessary to obtain maximum alignment indicated by dashes. Sequences were
aligned using DNAstar (Madison, WI.) software. The lengths of the composite cow
and dog cDNA sequences are 1 166 and 759 nucleotides, respectively.
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Figure 3. Comparison of the predicted neurotensin/neuromedin N precursor
sequences from rat, cow and dog. The complete precursor sequences are depicted
using the single letter amino acid code. Amino acids which are identical in all
three species are boxed.
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Figure 4. Determination Nucleaseof transcription initiation site. (A)
protection. A 32P- labeled single-stranded probe was hybridized to either 10
mg of rat hypothalamus (lanes 3 and 4), or jejunum- ileum (lanes 5 and 
poly(A)+ RNA, or total yeast RNA (lane 2) followed by digestion with either 50
(lanes 3 and 5) or 100 (lanes 2, 4 and 6) units of mung bean nuclease. The
products of the reaction were analyzed on a 6% polyacrylamide/7M urea gel.
Two arrows denote the major protection products. Undigested probe, lane 1;
dideoxy sequencing reactions using the template used to synthesize the probe
(GATC). (B) Primer extension. 32P- labeled single-stranded primer was
hybridized to 10 mg of either jejunum- ileum (lane 3), cerebrum (lane 4), or
testis (lane 5) poly(A)+ RNA, or total yeast RNA (lane 2) and extended with
reverse trancriptase. Reaction products were analyzed as described above.
Unreacted primer, lane 1; dideoxy sequencing sequencing reations (GATC). The
extension products can be directly positioned on the gene sequence and are
indic;ated by an arrow. (C) The positions of the probe used in (A) and the
primer used in (B) are depicted schematically. 5' flanking (thick line), 5'
untranslated (open bar), coding region (diagonal lined bar), and vector (thin
line) sequences are indicated. The extent of the probe, primer, protected
fragment, and the extent to which the primer was extended (zig-zag line) are
also indicated. To make the template, an Eco RI/ Hinf I fragment of rNT19 was
subcloned into M13mp11.
123 456 GATC
'1.
,;. j
50 bp
TATATATA
primer
51 probe
protected
Eco RI
Figure 5. RNA blot analysis. Poly(A)+ RNA was isolated from various adult rat
tissues, size-fractionated on a 1 % formaldehyde-agarose gel , transfered to a
Zetabind filter (Cuno, Meriden , Ct.), and hybridized with either of two 32P-
labeled single-stranded probes (panel C). Hybridizing bands were visualized
by autoradiography with an intensifying screen for 70 hours. 5 mg poly(A)+
RNA from brainstem, lane 1; cerebellum , lane 2; cerebrum , lane 
hypothalamus, lane 4; total brain, lane 5; duodenum-jejunum, lane 6; jejunum-
ileum , lane 7; large intestine, lane 8; testis, lane 9; kidney, lane 10; and liver
lane 11. The blot was hybridized with a probe (rNTB61) spanning coding region
and proximal 3' untranslated sequences (panel A), subsequently stripped, and
re- hybridized with a probe (3' UT- 1) spanning only the distal 3' untranslated
region (panel B). The probes are depicted schematically in panel C. Intron (thin
line), coding (diagonal lined bar), 3' untranslated (open bar), and 3' flanking
(thin line) sequences are indicated. The positions of two consensus poly(A)
addition signals and the extent of the anti-sense probes, rNTB61 and 3' UT-
are also indicated.
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MUTUALL Y DEPENDENT RESPONSE ELEMENTS IN THE CIS.
REGULATORY REGION OF THE NEUROTENSIN/NEUROMEDIN N
GENE INTEGRATE ENVIRONMENTAL STIMULI IN PCl2 CELLS
Kislauskis, E. and Dobner, P. R. (1990) Neuron 4, 783-795.
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ABSTRACT
The expression of the gene encoing the neuroendocrine peptides neurotensin and
neuromedin N is strictly dependent on simultaneous exposure to multiple
inducers in PC12 pheochromocyoma cells. NT peptide and NT/N mRNA levels
are synergistically induced by combinations of nerve growth factor,
dexamethasone, activators of adenylate cyclase, and lithium ion. We have used
transient transfection assays to delineate the rat neurotensin/neuromedin N gene
sequences necessary for this complex regulation. Progressive deletions of the 5'
flanking region revealed that sequences between -216 and +56 are sufficient to
confer the full spectrum of responses exhibited by the endogenous gene to a
reporter gene. Detailed mutational analysis of this region indicates that it is
composed of an array of inducible cis-regulatory sequences, including AP-
cyclic AMP response (CRE), and glucocorticoid response elements. Specific
mutation of either the AP-1 site or each of two CREs indicates that they are
functionally interdependent. This array of response elements serves to integrate
multiple environmental stimuli into a unified transcriptional response.
INTRODUCTION
Neurotensin (NT), a tridecapeptide, is widely expressed in both the central
nervous system and gastrointestinal tract (Reinecke, 1985). Sequence analysis
of cDNA and genomic clones has revealed the structure of a putative 169-170
amino acid precursor protein encoding NT, and a structurally related six amino
acid peptide, neuromedin N (Dobner et aI., 1987; Kislauskis et aI., 1988). 
has been implicated in the regulation of fat metabolism in the gut, and in diverse
functions in the central nervous system, where it is likely to serve as a
neurotransmitter or neuromodulator (Reinecke, 1985). Several lines of
evidence support a functional relationship between NT and catecholamines,
particularly dopamine (Nemeroff, 1980). Immunohistochemical localization
studies have provided suggestive evidence that NT is synthesized along with
catecholamines in subpopulations of catecholamine-containing neurons and
adrenal medullary cells (Terenghi et aI., 1983; Hokfelt et aI., 1984 
Interestingly, the PC12 adrenal medullary tumor cell line produces the
catecholamines dopamine and norepinephrine, and can be induced to synthesize
and secrete NT (Tischler et al. 1982; Tischler et aI., 1986; Dobner et aI.
1988).
PC 12 cells, like sympathetic neurons in primary culture, elaborate long
neurites in response to nerve growth factor (NGF) (Greene and Tischler, 1976).
Similar phenotypic plasticity is exhibited by adrenal chromaffn cells both in
tissue culture and in vivo (Aloe and Levi-Montalcini, 1979; Anderson and Axel,
1985; Doupe et aI. , 1985a; Doupe et aI., 1985b; Anderson and Axel, 1986).
Common precursor neural crest cells give rise to sympathetic neurons, adrenal
:' ,
chromaffin cells, and a diverse collection of other adult cell types (LeDouarin,
1980). A variety of transplantation and tissue culture experiments indicate that
environmental determinants, like NGF, dictate the final adult phenotypes adopted
by crest cell precursors (Landis and Patterson, 1981). Glucocorticoids and NGF
play key antagonistic roles in the decision between the adrenal medullary and
sympathetic neuronal phenotypes ( Unsicker et aI., 1978; Doupe et aI., 1985a;
Doupe et aI., 1985b; Anderson and Axel, 1986). Additional factors are likely to
be involved in the subspecialization of these cell types. For instance,
sympathetic neurons acquire cholinergic properties in response to factor
produced by heart myocytes and fibroblasts (Patterson, 1978). Thus, the
existence of multiple environmental determinants could help to account for the
numerous adult phenotypes adopted by crest cells. Additional diversity could
result from the combined influence of multiple environmental factors on single
cells.
The elaboration of different crest cell phenotypes is likely to require distinct
patterns of gene expression specific to each cell type (Anderson and Axel , 1985;
Anderson and Axel, 1986). The expression of several neural-specific mRNAs
and antigens is extinguished during chromaffin cell differentiation. In contrast,
NGF-induced phenotypic conversion of primary adrenal chromaffin cells is
accompanied by the increased expression of several neural-specific mRNAs.
Similarly, NGF treatment of PC12 cells results in changes in the expression of
numerous genes, including neural-specific genes (Levi et aI. , 1985; Anderson
and Axel , 1985; Leonard et aI., 1987; Milbrandt, 1987; Stein et aI., 1988).
Many of these genes are regulated in a reciprocal fashion by glucocorticoids, and
simultaneous treatment with both agents frequently results in an intermediate
level of expression (Leonard et aI., 1987; Stein et aI., 1988). Thus, the
antagonism exhibited by NGF and glucocorticoids in the choice between the
adrenal medullary and sympathetic neuronal phenotypes is reflected at the level
of specific gene expression in PC12 cells, even though NGF- induced neurite
outgrowth is not inhibited by glucocorticoids in these cells. These observations
provide preliminary evidence that the transcriptional responses evoked by
multiple environmental signals in crest cells may be more complex than the
separate responses to individual signals. The exposure of crest cells to multiple
environmental signals could indeed constitute a prerequisite for the expression of
certain genes.
NT/N gene expression in PC12 cells is strictly dependent on simultaneous
exposure to multiple inducers (Dobner et aI. , 1988). NT peptide and NT/N
mRNA levels are synergistically increased in PC12 cells by combinations of NGF,
dexamethasone, and activators of adenylate cyclase. Lithium ion, which inhibits
NGF- induced neurite outgrowth by PC12 cells (Burstein et aI., 1985), strongly
potentiates these responses. The gene is not detectably expressed in control cells,
and little or no detectable increase in expression is observed upon treatment with
individual inducers. High level expression requires simultaneous treatment with
three, or all four inducers. At maximum , intracellular levels of NT are
increased 1, OOO- fold over control values, accompanied by an increase in NT/N
mRNA levels of at least equal magnitude.
To understand the complex control of NT/N gene expression in PC12 cells, we
have delineated the rat NT/N gene cis-regulatory sequences necessary for
appropriate regulated expression in PC12 cells. Sequences between -216 and -
28 are sufficient to confer the full spectrum of responses exhibited by the
endogenous rat NT/N gene to a reporter gene driven by a heterologous minimal
promoter element. Detailed mutational analysis of this region indicates that it is
composed of an array of inducible cis-regulatory motifs. This control element is
capable of integrating inputs from multiple environmental stimuli at the level of
specific gene expression. We discuss the possible implications of such
integrative properties on the generation of diverse adult cell phenotypes from
common equipotent precursor cells.
RESULTS
Rat NT/N oene proximal 5 flankino sequences mediate responses to inducers.
To identify cis-regulatory sequences necessary for the regulated expression of
the rat NT/N gene, a series of plasm ids containing 5' flanking sequences fused to
the bacterial chloramphenicol acetyl transferase (CAT) gene were co-transfected
with a luciferase standardization plasmid into PC12 cells by electroporation
(Chu et aI., 1987). Transfected cells were plated in six well tissue culture
dishes, and after a 48 hr recovery period either treated with lithium alone or the
indicated combinations of NGF (100 ng/ml), dexamethasone (1 mM), forskolin
(1 mM), and lihium (20 mM) for 12 hr. The expression of a CAT fusion gene
containing 1.4 kb of 5' flanking sequence was induced to high levels in cells
treated with combinations of inducers, but not in lithium treated and control
cells (Figure 1 A). This pattern of expression was virtually unchanged by
further deletion of approximately 1.2 kb of sequences to -216. Similar results
were obtained with plasm ids containing either 5.0 kb more of 5' flanking
sequences, or various intragenic sequences cloned upstream of the 1.4 kb
promoter construct (data not shown). These results indicate that most if not all
of the cis-regulatory sequences required for induction are located within the -
216/+56 fragment.
Further 5' deletions revealed the approximate 5' end of the control region
(Figure 1 A). Deletion to -173 resulted in dramatically reduced responses
(;: 75%) to all combinations of inducers tested as compared to the -216
construct. A further decline in activity resulted upon deletion to - 102, and
plasm ids with deletion endpoints at -62 or -55 were nearly silenced. The -
plasmid, which contains only 12 base pairs upstream of the liT A T A" box, was
silent. These results locate the 5' boundry of the control region necessary for
full activity between -216 and -173. Interestingly, a perfect consensus AP-
sequence (Angel et aI., 1987) is located in this region (Figure 1 B). AP-1 sites
were first defined in a region of the human metallothionein gene necessary for
basal level expression, and in the SV40 enhancer (Lee et aI., 1987). This same
site was subsequently shown to mediate transcriptional responses to phorbol
esters (Angel et aI., 1987). The region between -216 and the liT AT A" box
contains several other near-consensus cis-regulatory motifs (Figure 1 B).
These include elements which in other genes mediate responses to either cyclic
AMP (CRE), or glucocorticoids (GRE). Two 21 base pair imperfect direct
repeats (IDR) are also located in this region.
To determine if the induction of CAT enzyme activity was the result of
increases in correctly initiated fusion gene transcripts, the -216/+56 CAT
fusion gene was transfected into PC12 cells. Following a 48 hr recovery period,
the indicated inducers were added for 12 hr, total RNA was prepared, and
transcripts were quantitated using a S1 nuclease protection assay (Figure 2A).
Fusion gene transcripts were detected using a 415 nucleotide 32P-labeled probe
spanning sequences from -43 to +56 of the rat NT/N gene and the first 253
nucleotides of the CAT gene. Hybridization with 40 mg of total RNA isolated from
cells treated with either all four inducers, or the combination NGF,
dexamethasone, and forskolin resulted in a 309 nucleotide protection product,
the size expected for correctly initiated transcripts (Figure 2A, lanes 3 and 4).
No fusion gene transcripts were detected in either lithium treated, or control
cells (Figure 2A , lanes 1 and 2). Similar results were obtained using a 32P-
labeled probe derived from exon four of the rat NT/N gene (Dobner et aI., 1988)
to detect endogenous transcripts (Figure 2A, lanes 9-12) and by measuring CAT
activity in extracts prepared from the same cells used for preparation of RNA
(Figure 2B). The relative increases in levels of fusion gene transcripts,
endogenous gene transcripts, and CAT enzyme activity upon treatment with either
three or four inducers were remarkably similar (Figure 2C). Thus, induction of
CAT activity is the result of correctly initiated transcription of the transiently
expressed fusion gene, and these increases closely parallel the responses of the
endenous gene.
The expression patterns of transfected CAT and luciferase fusion genes driven
by the rat NT/N -216/+56 promoter fragment were strikingly similar to that
of the endogenous NT/N gene in PC12 cells treated with all possible combinations
of NGF, dexamethasone, forskolin, and lithium (Figure 3). High level expression
of the endogenous rat NT/N gene (Figure 3, inset) and both reporter genes
required simultaneous treatment with combinations of three or all four inducers.
At maximum, reporter gene function was induced 600 to 1,200-fold over
control values, a response similar in magnitude to that of the endogenous gene.
Litte or no increases were observed in cells treated with individual inducers.
The small responses of the reporter genes to treatment with either forskolin or
lithium alone in this experiment are not reproducibly observed. Certain
pairwise combinations of inducers (dexamethasone and forskolin, forskolin and
lithium) more effectively stimulated expression of the transfected fusion genes
than is typical for the resident NT/N gene. Except for these minor differences,
the sequences between -216 and +56 of the rat NT/N gene appear sufficient to
confer the full spectrum of responses to inducers exhibited by the endogenous
gene.
To test wheth r rat NT IN 5' flanking sequences upstream of the rat NT /N
TATA" box could confer regulation to a heterologous promoter, sequences
between -216 and -28 were cloned in either orientation upstream of the rat
prolactin (PRL) "TAT A" box and 5' untranslated sequences (-39 to +38) linked
to CAT (Figure 4). PC12 cells were transfected with these plasmids, allowed to
recover, and treated with the indicated inducers for 12 hr. The induction profile
observed for both plasmids was similar to that obtained with the CAT fusion gene
driven by the wild type -216/+56 promoter fragment. Thus, the NT/N "TAT A"
box and downstream sequences can be substiuted by similar sequences derived
from the rat prolactin gene indicating that the cis-regulatory sequences
necessary for responses to inducers are located 5' to the liT A T A" box. The abilty
of the regulatory region to function in either orientation is suggestive 
enhancer function. However, a PRL promoter construct in which the -216/-
fragment was cloned downstream of the CAT gene was essentially silent even in
maximally induced cells suggesting that these sequences do not function in the
position- independent manner characteristic of most enhancers (data not shown).
Multiple response elements are necessary for full NT/N p ote activity.
series of linker scanner and internal deletion mutant constructs were analyzed to
more precisely map regulatory sequences in the 5' flanking region (Figure 5).
These mutants were created by joining appropriate 5' and 3' deletion clones via a
10 bp Bam HI linker. Mutant plasm ids were transfected into PC12 cells, and
following a 48 hr recovery period the cells were treated with either the indicated
combinations of inducers or no additives. The activity of each mutant relative to
wild type (-216/+56) for each induction condition is shown (Figure 5). The
activity of the wild type promoter in uninduced cells was very close to
background and this low level activity was not increased by any of the mutations
analyzed (data not shown). The mutations define both distal and proximal
domains of the regulatory region which are separated by two imperfect direct
repeats.
Two distal elements were identified. The first is a perfect consensus AP-
site located between the 5' deletion endpoints -216 and -173 (see Figure 1).
Two linker mutations (- 189/- 182, - 182/-173) which alter the AP- site
were analyzed and provide direct evidence for its function (Figure 5A).
Extensive alteration of the AP- sequence (- 189/- 182) resulted in
dramatically reduced responses (79-93%) to all inducer combinations tested.
Similar reductions ( 90% in most cases) were observed with linker mutant -
182/-173 in which the terminal A nucleotide of the AP-1 consensus sequence is
changed to a C, although the response to combined treatment with dexamethasone,
NGF , and lithium was less severely attenuated (67%). These results strongly
imply that the consensus AP-1 site is an important component of the NT/N
promoter and a focal point of synergistic interactions. The second distal element
is defined by linker mutation - 145/- 136 which changes four nucleotides of a
CGTCA motif. The human vasoactive intestinal peptide (VIP) promoter contains
two inverted repeats of this sequence both of which are required for full
transcriptional responses to cAMP (Tsukada et aI., 1987). The consensus CRE
(TGACGTCA) also includes this motif (Montminy et aI., 1986). Fusion genes
driven by the - 145/- 136 mutant promoter displayed dramatically reduced
responses (73-89%) to combinations of inducers which included the adenylate
cyclase activator, forskolin (Figure 5A). However, the response to combined
treatment with NGF, dexamethasone, and lithium was reduced only -two-fold.
Thus, the distal CGTCA (CRE) motif is required for maximal responses to
inducers, but mutation of this sequence has a more severe impact on inducer
combinations which include forskolin. The importance of this site is further
substantiated by the internal deletion mutant -145/- 125 in which the CGTCA
motif is partially deleted (Figure 5A). Interestingly, the analysis of 5' deletion
constructs (Figure 1 A, compare deletion plasm ids -150 and -120) did not
reveal the importance of this site indicating that its activity could depend on
upstream sequences, perhaps the AP-1 site.
The proximal domain is defined most precisely by the linker mutations -521-
43, and -58/-48 which alter CRE and GRE consensus sequences (Figure 5B).
The C R E- like sequences in the proximal domain (-52 to -41) consist of an
octamer (TGACATCA) which differs by one nucleotide from the consensus CRE
palindrome, and a CRE half repeat (GTCA) immediately upstream of the octamer.
This CRE- like octamer sequence is identical to an autoregulatory element located
upstream of the c-jun proto-oncogene which binds AP-1 complexes in vitro
(Angel et aI., 1988). Extensive alteration of the CRE- like sequences in linker
mutant -52/-43 resulted in dramatically reduced (;:85%) responses to inducer
combinations which include forskolin , but the response to combined treatment
with NGF, dexamethasone, and lithium was reduced only -2-fold. This biased
effect was more pronounced, but similar to that observed when the distal CRE-
like sequence was mutated (- 145/- 136, Figure 5A). The -58/-48 linker
mutation affects both the CRE- like sequences, and a GRE- like sequence which
differs by one nucleotide from a functional tyrosine amino transferase gene GRE
(Jantzen et aI., 1987). This mutation markedly curtailed responses (86-92%)
to all inducer combinations tested, and was the most severe mutation analyzed
(Figure 5B). Removal of portions of the GRE consensus sequence in two internal
deletion mutants (-129/-64, - 129/-56) selectively compromised responses
to inducer combinations which included dexamethasone (Figure 5B). This biased
effect was abolished by further deletion into the adjacent CRE consensus sequence
129/-43). These results taken together strongly suggest that a functional
GRE is located within the sequences deleted in the - 129/-64 and -129/-
internal deletion mutants. Surprisingly, extensive substitution of the distal
arm of the GRE in linker scanner mutant -73/-63 resulted in relatively mild
decreases in responses to all inducer combinations tested. One possible
explanation for this result is that the proximal half of the GRE is functional, but
only in the context of upstream sequences not present in the internal deletion
mutants. A functional estrogen response element half site has been characterized
in the chicken ovalbumin gene promoter (Tora et aI., 1988). The discrepancy
between the substitution and deletion mutants could also be due to effects of the
linker sequence or the context of the sequences in different mutants.
The sequences between the proximal and distal elements described above are
largely composed of two imperfect direct repeats (IDRs). The analysis of 5'
deletion constructs (Figure 1 A) suggested that the IDRs may be required for full
NT/N promoter function (compare deletion endpoints - 120 and - 102). Two
linker mutations in the distal IDR resulted in mild reductions in responses to
inducers (- 129/- 119, - 112/- 103) while a third (- 116/- 106) resulted 
increased responsiveness (Figure 5C). However, a consensus SP1 binding site
(Mitchell and Tjian , 1989) was created at the junction of the Bam HI linker in
the -116/-106 mutant. Since the SP1 transcription factor is widely, if not
- "
ubiquitously expressed, the SP1 site could account for the increased
responsiveness of the -116/-106 mutant. Two small deletions in the proximal
lOR (-100/-87, -90/-77) also had a relatively mild impact decreasing
induced activity -2-fold for all conditions tested. Deletion of both IDRs (-
115/-74) had very little effect on overall activity, however, a SP1 binding site
was adventitiously created by the Bam HI linker in this mutant and could have
replaced a lost function. These results taken together suggest that the IDRs may
be required for maximum responses to inducers, but are not essential
components of the regulatory region.
Expression in other cell lines. To determine whether the NT/N promoter
could function in other cell types, rat GH3 pituitary and Rat2 embryo fibroblast
celis were transfected with CAT fusion genes. Following a 48 hr recovery period,
cells were induced with various combinations of forskolin , dexamethasone, and
lithium for an additional 12 hr. NGF was not used since neither GH3 nor Rat2
cells have been reported to possess NGF receptors, and in preliminary
experiments NGF did not influence expression of transfected fusion genes in Rat2
cells (data not shown). The CAT fusion gene driven by the NT/N -216/+56
promoter fragment was active in both cell types, but displayed surprisingly
different patterns of expression (Figure 6). The fusion gene was expressed at
relatively high levels in un induced Rat2 cells, and expression was increased only
a modest 3-fold upon simultaneous treatment with all three inducers (Figure
6A). The high basal level expression was dependent on sequences between -216
and -43 since deletion of these sequences nearly silenced the promoter (Figure
6A). In contrast, the expression of the CAT fusion gene driven by the -216/+56
promoter fragment was highly dependent on treatment with inducers in GH3 cells
(Figure 6B), and is reminiscent of the expression pattern in PC12 cells. 
notable difference is the induction of fusion gene expression in response to
treatment of GH3cells with just forskolin. These results indicate that the -
216/+56 NT/N promoter fragment is active in diverse cell types, but displays
strikingly different patterns of expression in fibroblasts, and endocrine and
neuroendocrine cell types.
DISCUSSION
Multiple response elements. We have used transient transfection assays to
examine the sequence requirements for appropriate synergistic regulation of the
rat NT/N gene in PC12 cells. Sequences between -216 and +56 are sufficient to
confer the full spectrum of responses exhibited by the endogenous gene to two
different reporter genes. At maximum , reporter gene function is induced 600-
to 1 ,200-fold over control values, a response similar in magnitude to that of the
endogenous gene (Dobner et aI., 1988). Sequences between -216 and and -
function in a relatively orientation-independent manner, suggestive of enhancer
function. Although we have not examined position-dependence in detail, this
fragment did not function when cloned downstream of a CAT gene driven by a
minimal promoter.
The analysis of linker scanner and deletion mutants which span sequences
between -216 and the "TAT A" box indicates that the control region can be
functionally divided into two domains, proximal and distal, separated by two
imperfect direct repeats. The distal domain contains consensus AP- 1 and CRE
sequences while the proximal domain includes near consensus GRE and CRE
sequences. Specific mutation of these elements revealed, in most cases, that they
play key roles in the overall function of the control region. Mutations in the AP-
1 and CGTCA (CRE) sequence motifs in the distal domain
, and the TGACA TCA (CRE)
sequence motif in the proximal domain sharply diminish responses to most
inducer combinations. Interestingly, most mutations in the two CRE and GRE
consensus sequences had biased effects on inducer combinations which included
-:,- ,
forskolin or dexamethasone, respectively (see below). In contrast, the AP-
site appears to participate in responses to all productive inducer combinations.
The effect of inducers on NT /N gene expression is clearly synergistic.
Individual inducers have virtually no effect on the expression of the gene, while
treatment with three or all four inducers results in high level expression.
Synergy could be generated at the level of the gene, at the level of signal
transduction, or at both levels. The severe impact of mutating the AP-1 site or
either of two CREs within the NT/N promoter on the responses to different
combinations of inducers suggests that these sites may be functionally
interdependent. Synergy between different classes of sites which bind distinct
transcription factors and between multiple copies of single sites is a common
feature which has emerged from the examination of a variety of enhancers and
complex promoters (Dynan, 1989). Inducible response elements are frequently
found tightly associated with other transcription factor binding sequences, and in
some cases are dependent on these sites for high level activity. AP- 1 sites within
a basal enhancer element of the metallothionein promoter and the SV40 enhancer
display a marked dependence on adjacent SP1 and AP-4 sites, respectively, for
transcriptional activation in vitro (Lee et aI., 1987; Mermod et aI., 1988).
Similarly, a sequence which confers responses to cAMP and phorbol esters in the
upstream region of the human proenkephalin gene is composed of multiple
interdependent sequence elements, including an essential CGTCA (CRE) motif
(Comb et aI., 1989; Hyman et aI. , 1989). Multiple sites of a single functional
class are also frequently observed to act cooperatively (Tsukada et aI., 1987;
Schule et aI., 1988; Strahle et aI., 1988).
Functional synergy between the AP-1 and CRE sites could account, at least in
part, for the requirement for multiple inducers to obtain high level NT/N gene
expression. Each of these types of sites could be bound by distinct transcription
factors which are separately regulated by different inducers, and since each site
functions only poorly by itself, high level expression would result only when
both factors are present in an active form. However, the consensus AP-1 and
CRE sequences are closely related, and, although they appear to bind different
proteins or protein complexes in many circumstances, recent evidence suggests
that there may be at least some overlap in the proteins which bind these related
sequences (see below). Thus, an additional possibility is that synergy could be
generated through the combined effects of inducers, for instance multiple
phosphorylations, on a single protein or protein complex which binds to both the
AP- 1 and CRE sequences. These mechanisms are not necessarily related, but are
also not mutually exclusive. For each of these possibilities, the apparent
interdependence of the AP-1 site and the CREs within the NT/N promoter region
could account, at least in part, for the high degree of synergy observed in the
induction of NT/N gene expression in PC12 cells.
Whether or not the GRE may also function in an interdependent manner is less
clear. Several internal deletion mutants indicate that the GRE consensus sequence
actually mediates transcriptional responses to glucocorticoids within the context
of the NT/N promoter, although a linker mutant which altered the distal half of
the GRE had a comparatively mild effect on activity. The remaining half
palindrome of the GRE in this mutant could retain function, since hormone
responsive half sites. have been observed in other genes (Tora et aI. , 1988). The
GRE appears to be only weakly active since the addition of dexamethasone with
different combinations of inducers typically increases the expression of fusion
genes driven by the wild type NT/N promoter only 2 to 5-fold (see Figures 1 and
3). Weakly active GREs have been demonstrated to act synergistically with a
variety of DNA binding sites (Schule et aI., 1988; Strahle et aI., 1988). The
GRE within the NT/N promoter could depend on either the AP- 1 site, the CREs,
or both classes of sequences for activity. However, a two-fold effect would be
particularly difficult to discern in the context of a mutated AP-1 site or CRE
where the activity of the NT/N promoter has been reduced to 10% of the wild
type level. Thus, the GRE could function independently of the other sites.
The NT/N Qene as a possible downstream tarQet of NGF action. NGF treatment
of PC12 cells results in the rapid transient activation of a class of cellular genes,
termed early response or immediate early genes, typified by the c- fos and c-jun
proto-oncogenes (Curran and Morgan, 1985; Greenberg et aI., 1985; Kruijer et
aI., 1985). The protein products of these two proto-oncogenes form
heterodimeric complexes which bind the AP- 1 site with high affinity in vitro
(Kouzarides and Ziff, 1988; Sassone-Corsi et aI., 1988), and are present in
purified preparations of AP- 1 (Bohmann et aI., 1988). However, purified AP-
1 complexes are heterogeneous and contain additional fos-related, and jun-
related proteins (Bohmann et aI., 1988; Curran and Franza, 1988). At least two
fos-related (Fos B , fra 1) and two jun-related (jun B, jun D) cDNAs have been
cloned, and the proteins encoded by these cDNAs are capable of forming
heterodimers which bind the AP-1 site with high affinity in vitro (Nakabeppu et
aI., 1988; Halazonetis et aI., 1988; Cohen et aI., 1989; Hirai et aI. , 1989;
Rauscher et aI., 1989; Zerial et aI., 1989). The protein products of the c-jun
Jun-B, and Jun-D genes are also capable of binding to the AP-1 sequence as
homodimers, but with lower affinity than when com pie xed with Fos (Nakabeppu
et aI., 1988; Hirai et aI., 1989). They also bind the related CRE with around
10-fold lower affinity than the AP-1 sequence and this activity is not enhanced
by Fos (Nakabeppu et aI., 1988). These different complexes may differentially
regulate specific promoters. For instance, c-jun efficiently activates promoters
containing either single or multiple AP-1 sites while Jun B inhibits expression
of promoters containing single AP-1 sites and activates expression from
promoters containing multiple sites (Chiu et aI., 1989). The transcriptional
regulation of the fos-related and jun-related genes appears to be a major level at
which AP-1 activity is controlled in the cell, although both Fos and Jun are
subject to post- translational modification which could also regulate their
activity (Franza et aI., 1987; Angel et aI. , 1988). NGF induces both c-jun and
jun B transcription, and the appearance of a set of fos-related proteins in PC12
cells (Franza et aI., 1987; Bartel et aI., 1989). At least some fos-related
proteins are induced more slowly and persist longer than c-fos (Franza et aI.,
1987). The rapid activation of genes encoding transcription factors (like c-fos
and c-jun) by NGF has led to the proposal that these proteins in turn activate
genes involved in neuronal differentiation, although the downstream targets of
this initial cascade have not been identified to our knowledge.
The presence of a functional AP- 1 site in the NT/N promoter regulatory
region is suggestive that the NT/N gene constitutes such a downstream target,
specifically of AP-1 complexes, and that NGF may exert its influence, at least in
part, through this site by increasing the levels of these complexes. The transient
induction of AP- 1 complex genes and proteins in response to NGF leads to the
prediction that the expression of downstream genes might also be transiently
induced. Consistent with this prediction, we observe a transient burst in the
accumulation of unspliced nuclear NT/N pre-mRNAs which reaches a peak 3-
hr after combined treatment of PC12 cells with NGF, dexamethasone, forskolin,
and LiCI (B.P. Bullock and P. D., unpublished results). These kinetics are
similar to the more delayed transient appearance of fos-related antigens in PC12
cells (Franza et aI., 1987). Specific mutation of the AP-1 site in the NT/N
promoter decreased responses to all inducer combinations by about an order of
magnitude, perhaps indicating that multiple inducers act through the AP-1 site.
Indeed, AP-1 sites cloned upstream of the human gonadotropin a-subunit gene
mediate transcriptional responses to both cAMP and phorbol esters, and the two
agents together result in synergistic responses in HeLa cells and the JEG-
choriocarcinoma cell line (Deutsch et aI., 1988; Hoeffer et aI., 1989).
However, this dual regulation was not observed in HeLa cells with a b-globin
gene construct driven by multimerized AP-1 sites (Imagawa et aI., 1987). 
PC12 cells, forskolin does not increase expression of a CAT fusion gene driven by
a promoter containing multimerized AP- sites, however, this construct 
activated by either NGF, or lithium treatment (E.K. and P. D., manuscript in
preparation). Thus, the AP-1 site within the NT/N promoter is likely to be a
focus of both NGF and lihium action in PC12 cells.
Recently, seizure activity has been shown to induce the expression of c-fos,
c-jun, and related genes in specific regions of the brain , particularly the
hippocampus (Curran and Morgan , 1987; Morgan et aI. , 1987; Saffen et aI.,
1988; Sagar et aI., 1988; Sonnenberg et aI. , 1989a). These increases result in
a protracted increase in AP-1 activity which appears to depend on the sequential
appearance of Fos and several fos-related antigens (Sonnenberg et aI., 1989a).
Seizure activity also results in increased preproenkephalin gene expression in
the hippocampus, and the expression of a CAT fusion gene driven by the
preproenkephalin promoter is induced by cotransfection with c-fos and c-jun
expression plasm ids suggesting that AP-1 complexes regulate neuropeptide gene
expression in the brain (Sonnenberg et aI., 1989b). The NT/N gene is expressed
widely in the rat forebrain including the CA 1 region of the hippocampus
(Alexander et aI., 1989). The AP-1 site identified by transfection into PC12
cells could also be required for NT /N gene expression in the central nervous
system.
Biased effect of mutations in the CREs and GRE. Specific mutations in either of
two CRE- like sequences and deletion mutations which remove part of the GRE
consensus sequence had biased effects on responses to inducer combinations.
Mutations in either the distal or the proximal CRE- like sequences selectively
attenuated responses to inducer combinations which included the adenylate
cyclase activator forskolin , supporting their function as CREs. This selective
effect is particularly apparent when the proximal CRE- like sequence is mutated.
Similarly, responses to inducer combinations which included dexamethasone
were selectively compromised by removal of portions of the GRE consensus
sequence in two internal deletion mutants (- 129/-64 and - 129/-56). When
the internal deletion extended further into the proximal CRE- like sequences (-
129/-43), the selective effect was abolished and all responses to inducers were
severely compromised. These results taken together suggest that there is 
functional GRE within the region deleted in the - 129/-64 and - 129/-
mutants, most likely the GRE consensus sequence. Likewise, the CRE consensus
sequences appear to be primarily required for responses to forskolin. However,
none of these sequences were capable of mediating a simple response in PC12
cells to any of the inducers tested when they were used individually.
The selective effects of mutations in the CRE and GRE sequences suggest that
synergy may be generated at a step distal to signal transduction, perhaps through
binding of transcription factors, or transcriptional activation by these factors.
The close match of the CRE and GRE sequences to consensus suggests that the
glucocorticoid receptor, and the major CRE-binding protein in PC12 cells
(CREB) may be involved. The glucocorticoid receptor is a ligand-dependent
transcriptional activator (reviewed by Evans, 1988) while CREB activity is
modulated by phosphorylation by protein kinase A (Gonzalez and Montminy,
1989). The dimerization of CREB is increased in vitro by phosphorylation with
protein kinase C indicating that CREB activity may be modulated by more than one
kinase (Yamamoto et aI. , 1988). The recent demonstration that aCRE-driven
reporter plasmid is activated when co-transfected with a c-jun expression
plasmid suggests that Jun could also be involved in regulation through the CRE
(Chiu et aI., 1989). In fact, the proximal CRE in the NT/N promoter is identical
to an autoregulatory site upstream of the c-jun gene which binds AP-
complexes in vitro (Angel et aI., 1988). Thus, although the biased effect of
mutating either CRE is suggestive that these sequences actually function as CREs,
most likely by binding CREB, we cannot rule out the possibility of other
interactions. In fact, CREB is only one member of a family of CRE-binding
proteins (Hai et aI., 1989; Maekawa et aI., 1989 ) and at least one other
member of the family is expressed in PC12 cells (Maekawa et aI., 1989). The
availabilty of cloned genes for these proteins, and various AP-1 complex
proteins should enable us to examine the mechanisms underlying the highly
synergistic operation of the NT/N promoter.
Generating phenotypic diversity in neural crest progenitor cells.
Immunohistochemical co- localization studies have demonstrated that NT is
produced in a subpopulation of catecholamine-containing adrenal medullary cells
in cats (Terenghi et aI., 1983) and subpopulations of catecholamine-containing
neurons in the rat central nervous system (Hokfelt et aI., 1984). NT may also
be produced by principal sympathetic neurons, although this has not been clearly
established (Reinecke, 1985). These in vivo correlates suggest that the
regulated expression of NT in the catecholamine-producing PC12 cell line may
indeed be representative of expression in the intact animal. Two of the inducers
we have used, NGF and the synthetic glucocorticoid, dexamethasone, represent
important environmental determinants which influence the differentiation of
neural crest cells (Landis and Patterson , 1981). NGF is essential for the
development and survival of sympathetic and some sensory neurons, and perhaps
adrenal medullary cells (Aloe and Levi-Montalcini , 1979; Levi-Montalcini
1987). In addition, intracellular levels of cAMP might be influenced in crest-
derived cells by circulating hormones, or neurotransmitters (Walicke and
Patterson , 1981). Lithium is not a physiological regulator, but is used
extensively for the treatment of manic-depressive illness (reviewed by Berridge
et aI., 1989). The effects of lithium on NT/N gene expression are paradoxical in
view of its known negative influence on both the cyclic AMP and
phosphatidylinositol signal transduction pathways. The results presented here
clearly indicate that lihium can influence gene transcription, possibly by
stimulating a cellular pathway that normally responds to one or more
environmental determinants.
The evidence presented here indicates that the NT/N gene promoter serves to
integrate multiple environmental signals in PC12 cells into a unified
transcriptional response. This property may have important implications for
the generation of phenotypic diversity in neural crest progenitor cells. Such
promoters could restrict the expression of particular sets of genes to limited
populations of adult crest derivatives which have migrated to an environment
which provides the necessary multiple cues. Although NGF and glucocorticoids
appear to be the major determinants involved in the decision between the
sympathetic neuronal and adrenal medullary phenotypes, other agents could
influence the further diversification of these basic cell types. The acquisition of
cholinergic properties by sympathetic neurons provides an example of such sub-
specialization , and requires a factor produced by fibroblasts and heart myocytes
(Patterson, 1978). As has been suggested elsewhere, pleuripotent neural crest
cells could maintain batteries of genes, required in various specialized cell
types, in a chromatin conformation that permits transcription, but the actual
genes expressed would be determined by environmental signals (Anderson and
Axel, 1985). By making the expression of certain genes or sets of genes
dependent on multiple stimuli, a relatively small number of environmental cues
could specify a large number of adult cell phenotypes.
EXPERIMENTAL PROCEDURES
Plasmid Constructions. To construct pUCAT, the Hind II site of pSV2CAT
(Gorman et aI., 1982) was converted to a Sac I site, the resulting plasmid was
digested with Sac I and Bgi II, the 1.6 kb fragment containing the
chloramphenicol acetyl transferase (CAT) gene and SV40 splice and
polyadenylation signals was gel- isolated, and ligated into a Sac I/Bgl II digested
pUC19 derivative in which the Eco RI site had been converted to a Bgi II site.
Plasmids containing various amounts of rat gene 5' flanking sequences were
constructed by ligating various promoter fragments into pUCA T. Initial
promoter fragments were prepared from a subcloned 3.5 kb Hind III fragment
containing exon one, part of intron one, and approximately 1.4 kb of 5' flanking
sequences of the rat NT/N gene. Fragments were prepared by digestion with Sac I
which cuts at nucleotide +55 within the 5' untranslated region, and either Hind
III (-1414), Bam HI (- 1056), Bgi II (-570), or Pst I (-216), followed by
ligation into pUCA T digested with the appropriate enzymes. Additional plasm ids
containing intragenic sequences were constructed by ligation of several Hind III
fragments derived from subclones of the NT/N gene into the -1414 plasmid at
the Hind III site. A plasmid containing additional 5' flanking sequences was
constructed by ligating a 5.0 kb Bam HI fragment into the - 1056 plasmid at the
Bam HI site. The resultant plasmid contains approximately 6 kb of contiguous 5'
flanking sequence.
5' and 3' deletions were created from a plasmid containing a Pst I/Sac I
fragment of the rat NT/N gene encompassing sequences from -216 to +56. For
5' deletions, the plasmid was linearized at the polylinker Hind III site followed by
either Bal 31, or exo III/mung bean nuclease digestion. Bam HI linkers
(CGGGATCCCG) were added, DNA was digested with Bam HI, and recircularized.
Selected deleted plasm ids were digested with Bam HI and Sac I, the liberated
insert was isolated and ligated into Bam HI/Sac I digested pUCA T. 3' deletions
were constructed similarly except that the initial digestion was with Sac I.
linker scanner mutants were created by combining appropriate 5' and 
deletions as described (McKnight and Kingsbury, 1982).
Rat NT/N gene sequences between -216 and -28 were cloned in either
orientation upstream of the rat prolactin gene "TATA" homology and cap site in a
pUC9 based vector (pPRLCAT) containing the rat prolactin minimal promoter
(Lufkin and Bancroft, 1987). The insert fragment was obtained from a 3'
deletion mutant of the -216 (Pst I site) to +56 (Sac I site) fragment in which
sequences between -28 and +56 were deleted and a Bam HI linker was attached.
The Pst I site was converted to a Bam HI site and the insert was removed by
digestion with Bam HI and ligated into a Bgi II digested pPRLCA T plasmid
derivative in which the Sal I site had been converted to a Sgl II site. To obtain
inserts downstream of the CAT gene, pPRLCAT was digested with Sam HI.
The two luciferase control plasmids used were pRSV/L (de Wet et aI. , 1987),
and pPSLUC which was created by cloning a Pst I/Sac I rat NT/N promoter
fragment encompassing sequences between -216 and +56 into Pst I/Sac I
digested pXP2 which contains the firefly luciferase gene (Nordeen , 1988).
Luciferase and CAT assays. Following induction , cells were pelleted in a
microcentrifuge for 2 sec., washed with ice-cold phosphate buffered saline,
washed with extraction buHer, resuspended in 200 ml of extraction buffer (100
mM potassium phosphate (pH 7.8), 1 mM dithiotreitol), and disrupted by three
cycles of freezing and thawing. Cell debris was pelleted in a microcentrifuge for
5 min. at 4 C, and protein concentrations were determined by Coomassie
briliant blue G250 binding (Bradford, 1976). Luciferase assays were
performed with 20 mg of protein as described (de Wet et aI., 1987) using a
model 2010 luminometer (Analytical Luminescence Laboratories, San Diego,
CA). CAT assays were performed as described (Gorman et aI., 1982) using 0.
mCi 14C-chloramphenicol (Amersham) and 20 mg protein in a 1 hr reaction,
except for Rat2 cell extracts where 5 mg was used.
To control for variations in transfection efficiency , CAT activity was
standardized to luciferase activity as follows: Luciferase activity was determined
for each sample (at least in duplicate) and corrected for background 
subtracting the activity determined for an extract prepared from mock-
transfected cells. These values were then normalized by dividing each one by the
average luciferase activity obtained in all extracts under the same induction
condition. The normalized luciferase activities were then used to standardize the
CAT activities measured in the corresponding extracts. Corrected CAT activity is
the measured activity (% 14C-chloramphenicol converted to acetylated forms)
divided by the normalized luciferase activity. For the analysis of linker and
internal deletion mutants, relative CAT activity was calculated by dividing the
corrected CAT activity for a given mutant by the corrected CAT activity obtained
with the parental wild-type plasmid (-216/+56). We note that expression
from RSV/L (de Wet et aI. , 1987) was reproducibly induced around 10-fold by
lithium either alone or in combination with other inducers in PC12 cells. This
was not due to an enhancement of DNA uptake or retention since a CAT fusion gene
driven by the Herpes Simplex virus thymidine kinase promoter was not induced
by lithium.
Cell culture and electroporation. PC12 cells (Greene and Tischler, 1976)
were maintained in Dulbecco minimum essential medium (DMEM)
supplemented with 10% heat-inactivated horse serum, 5% fetal bovine serum,
50 units/ml penicilln, 50 mg/ml streptomycin (all from GIBCO) on plastic
tissue culture dishes. GH3 cells were grown as described (Lufkin and Bancroft,
1987). Rat2 cells were grown in DMEM supplemented with 5% calf serum
(Hazleton, Lenexa, KS). Electroporation of DNA was performed as described
(Chu et aI., 1987) using a single pulse from a 960 mF capacitor (Gene pulser
Biorad) charged to either 200 V (PC12 celis), or 300 V (GH3 and Rat2 cells).
Typically PC12 and GH3 cells were transfected with 25 mg of CAT plasmid and
5 mg of luciferase plasmid. The amounts of each plasmid were doubled for Rat2
cells. Following electroporation, cells were plated onto either six well (-2 x
106 cells/well) or 100 mm (5 x 106 cells) plastic tissue culture dishes and
allowed to recover for 48 hr. Cells were induced with appropriate combinations
of NGF (100ng/ml), dexamethasone (1 mM), forskolin (1 mM) and. LiCI (20
mM) for 12 hr. NGF was either prepared as described (Mobley et aI., 1976), or
purchased from Bioproducts for Science. Inc. (Indianapolis, IN). Dexamethasone
was a gift from Merck Sharp and Dohme, LiCI was from Fluka, and forskolin was
from Sigma.
RNA analysis. RNA was extracted from PC12 cells by the liCVurea extraction
procdure, and S1 nuclease protection assays were performed using 32P- labeled
single-stranded DNA probes as descibed (Dobner et aI., 1988).
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Figure 1. Transient transfection analysis of 5' deletion clones
(A) PC12 cells were transfected with plasm ids (25 mg) containing the indicated
rat NT/N gene 5' flanking sequences cloned upstream of the bacterial CAT gene in
pUCAT. To control for variations in transfection efficiency, 2.5 mg of a control
plasmid in which the firefly luciferase gene is driven by the rat NT/N -216 to
+56 promoter fragment (pPSLUC) was co-transfected in each case. Following a
48 hr recovery period, cells were treated with the indicated combinations of
inducers for 12 hr, harvested, and assayed for CAT and luciferase enzyme
activity using 20 mg protein for each assay . CAT activity (% conversion of 14C-
chloramphenicol to acetylated forms per 20 mg protein) for each induction
condition is plotted (corrected for variations in luciferase activity as described
in Materials and Methods). The deletion endpoints are depicted schematically
below the abscissa. The positions of sequences similar to consensus AP- 1, cyclic
AMP (CRE) and glucocorticoid response (GRE) elements, and two imperfect
direct repeats (IDR) are indicated. The induction conditions are indicated and the
inducers are abbreviated as follows: NA , no additives; L, 20 mM LiCI; 0, 
dexamethasone; F , 1 forskolin; N, 100ng/ml NGF. (B) The nucleotide
sequence of the 5' flanking region of the rat NT IN gene between -216 and +1.
Sequences similar or identical to consensus sequences for AP- 1, CRE. GRE, and
the TAT A box are boxed. The two IDRs are underlined.
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Figure 2. Increases in CAT activity are accmpanied by similar increases in the
levels of accurately initiated fusion gene transcripts
(A) PC12 cells were transfected with 25 mg of a CAT fusion gene plasmid driven
by the rat NTIN -216/+56 promoter, plated onto 100 mM dishes, allowed to
recover, and treated with combinations of inducers as in Figure 1. Total RNA
was prepared from "1 x 107 cells for each condition tested. Fusion and
endogenous gene transcripts were quantitated by hybridizing 32P- labeled
single-stranded DNA probes with either 40 mg or 5 mg of RNA, respectively,
followed by S1 nuclease treatment. The reaction products were analyzed on
sequencing gels and visualized by autoradiography for either 12.5 hr (lanes 1-
6) or 3.5 hr (lanes 7-13) with an intensifying screen. The probes and expected
protection products are depicted schematically. The exon four probe spans 336
nucleotides of rat NT/N gene sequences (thick bar) including the neuromedin N
(diagonal fill) and neurotensin (black fil) coding domains. The fusion gene
probe contains rat NT/N sequences between -43 and +56 (thick open bar), and
the first 253 nucleotides of the CAT gene (thick stippled bar). Vector sequences
are represented by thin lines. Fusion gene probe, lanes 1- , and 6; rat NT/N
gene exon 4 probe, lanes 7-12. RNA from transfected PC12 cells treated with no
additives, lanes 1 and 9; liCI, lanes 2 and 10; NGF, dexamethasone, and
forskolin, lanes 3 and 11; NGF, dexamethasone, forskolin , and liCI , lanes 4 and
12. The concentrations of additives were as in Figure 1. Lanes 5 and 13.
radiolabeled DNA size standards (upper, 396 bases; lower, 350 bases); lanes 6
and 8, control reactions with either 40 mg or 5 mg yeast RNA , respectively;
lane 7, undigested exon 4 probe. The expected protection products are indicated
by arrows. (B) CAT assays were performed using protein extracts prepared
from the same cells used in (A). The induction conditions are indicated using the
single letter abbreviations used in Figure 1. (C) Quantitation of fusion gene
transcripts (diagonal fil), endogenous gene transcripts (black bars), and CAT
enzyme activity (horizontal fill). Transcripts levels were quantitated either by
direct counting on a Betascope analyzer for the exon 4 probe (CPM x 10- ) or
by densitometric scanning of an autoradiograph for the fusion gene probe
(arbitrary scanner units). CAT enzyme activity is expressed as in Figure 
Induction conditions are indicated as in (B).
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Figure 3. Synergistic induction of transiently expressed fusion gene constructs
PC12 cells were co-transfected with CAT and luciferase fusion gene plasmids
driven by the -216 to +56 rat NT/N gene promoter fragment and induced. The
induction conditions, abbreviations, and concentrations of inducers are as in
Figure 1. CAT (open bars) and luciferase (black bars) enzyme activities were
determined, and used to calculate the fold- induction over control values (no
additives). Background values for the two assays were determined using an
extract prepared from mock transfected PC12 cells, and subtracted. In a
separate experiment, endogenous NT/N gene transcripts were analyzed by S1
nuclease protection using a 32P-labeled exon four probe as in Figure 2A. The S1
nuclease protection products were analyzed on a sequencing gel and visualized by
autoradiography (inset). The position of the expected protection product is
indicated by an arrow. The induction conditions were the same as for the
transfection experiment except cells were induced for 40 hr.
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Figure 4. The NT/N gene control region functions in either orientation upstream
of a heterologous promoter
NT/N gene sequences between -216 and -28 were cloned in either orientation
upstream of a minimal prolactin promoter fused to the CAT gene, and the
resulting plasmids were transfected into PC12 cells. The cells were treated with
the indicated combinations of inducers and CAT and luciferase enzyme activities
were determined. The fusion gene constructs are depicted schematically.
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Figure 5. Mutational analysis of the NT/N promoter
A series of linker scanner and internal deletion mutants were constructed from
the -216/+56 wild type rat NT/N promoter fragment and cloned upstream of the
CAT gene in pUCAT. The activity of each plasmid was determined by transient
transfection into PC12 cells and compared to the activity of the parent wild type
plasmid. Several separate transfection experiments were performed to evaluate
all the constructs and each set included the parent wild type plasmid for
comparison. To control for variations in transfection efficiency within an
experiment, a control luciferase plasmid was co-transfected, either RSV/L (de
Wet, Wood et aI., 1987) , or pPSLUC (see Fig. 1), and luciferase activity was
used to correct CAT activity as described in Materials and Methods. All
constructs were evaluated at least twice except for those in panel (C). The
activity of the mutants is expressed relative to wild type activity (% conversion
mutant/% conversion wild type). The location and extent of linker scanner
(open box) and internal deletion mutations are depicted schematically. The
numbers refer to the 5' and 3' endpoints of each mutation. The induction
conditions tested are indicated alongside the histogram for the - 189/- 182
mutation. The single letter abbreviations and concentrations of inducers used are
as in Figure 1. Conditions not tested are indicated by an asterisk. Mutations 
the distal (A) and proximal (B) domains, and the region between these domains
(C) were analyzed.
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Figure 6. Expression in Rat2 fibroblasts and GH3 pituitary cells
(A) 50 mg of either the wild type -216/+56 CAT plasmid (as evaluated in PC12
cells), or the -43/+56 5' deletion plasmid, which retains only the rat NT/N
TAT A box and 5' untranslated region (see Figure 1), were transfected into Rat2
cells as described in Materials and Methods. Following a 48 hr recovery period,
cells were treated with the indicated combinations of inducers for 12 hrs, then
harvested. The concentrations and single letter abbreviations of the inducers are
as in Figure 1. 5 mg of the RSV/L luciferase control plasmid was co-transfected
in each case. CAT activity was determined using 5 mg of protein and is plotted as
in Figure 1.
(B) The -216/+56 CAT plasmid was assayed in GH3 rat pituitary cells as
described for Rat2 cells in (A) except that 25 mg of the plasmid was transfected
and CAT activity was determined using 20 mg of protein.
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NERVE GROWTH FACTOR AND LITHIUM SELECTIVELY ACTIVATE
PROMOTERS CONTAINING MULTIPLE AP-1 SITES IN PC12 CELLS
Kislauskis, E., Wagner, J. A., and Dobner, P.D. (submitted for publication).
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ABSTRACT
Treatment of PC12 cells with nerve growth factor (NGF) results in the rapid
transcriptional activation of several genes encoding AP-1 transcription factors,
suggesting that AP-1 may be involved in NGF- induced neuronal differentiation 1,
NGF also acts permissively in the synergistic regulation of
neurotensin/neuromedin N gene expression in PC12 cells by NGF,
glucocorticoids, and activators of adenylate cyclase 6, 7 Surprisingly, lithium
can substitute for NGF in this permissive role. These transcriptional effects
require mutually dependent AP-1 and cAMP-response elements (CREs) located
within 200 bp of the NT/N gene transcriptional start site 7. To further examine
the role of these sites in NTIN promoter function, we examined the effects of
inducers on the expression of CAT fusion genes driven by promoters containing
either single or multiple sites of each class in PC12 cells. Both NGF and lihium
treatment resulted in the striking activation of promoters containing multiple,
but not single AP- sites. Both agents also potentiated forskolin- induced
activation of promoters containing CREs. These results suggest that promoters
containing multiple AP- 1 sites, or a single AP-1 site in the context of nearby
active CREs, are selectively activated by either NGF or lithium in PC12 cells.
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RESULTS AND DISCUSSION
To examine the effects of inducers on promoters containing AP- 1 sites,
chloramphenicol acetyltransferase (CAT) fusion genes controlled by the herpes
simplex virus thymidine kinase promoter (pBLCat4) and single (1 xAP- 1), or
multiple (5xAP-1) AP- sites 8 were transiently expressed in PC12 cells
treated with inducers for 12 hr (Fig. 1). Lithium (20 mM) treatment resulted
in a striking 58- fold induction of 5xAP- 1 CAT expression, but had little effect
on either 1 xAP-1 or pBLCat4 plasmids. NGF and phorbol 12-myristate 13-
acetate (PMA) also selectively activated 5xAP-1 expression , although less
effectively than lithium. Treatment with the adenylate cyclase activator,
forskolin, resulted in a small, but reproducible, 5-fold stimulation of 5xAP-
CAT activity. Combinations of inducers acted additively to selectively increase
5xAP- 1 expression by over 100-fold at maximum in sharp contrast to their
synergistic effect on NT/N gene expression 6, 7
The expression of CAT fusion genes driven by promoters containing CREs
markedly differed from those controlled by AP- 1 sites. Neither NGF nor lithium
alone activated promoters containing single (1 xCRE) or multiple (4xCRE) CREs,
although both types of promoters were activated (3- and 9-fold, respectively)
in response to forskolin treatment of PC12 cells (Fig. 2). However, both
lithium and NGF acted synergistically with forskolin to activate promoters
containing either single or multiple CREs. Lithium cooperated more effectively
with forskolin to activate 1 xCRE and 4xCRE CAT expression by 18- and 57-fold,
respectively. Both forskolin induction and potentiation by lithium and NGF were
dependent on protein kinase A activity, since the 4xCRE CAT fusion gene was not
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regulated in mutant A 126-1 B2 cells 9 deficient in protein kinase A activity
(Fig. 2c). Forskolin activation of promoters containing multiple AP- 1 sites was
similarly compromised in the kinase A deficient mutant, while the selective
activation of such promoters by lithium or NGF was relatively unimpaired (Fig.
1 c).
Mutational analysis of the NT/N promoter indicates that the AP-1 site and
CREs are functionally interdependent suggesting that these elements serve to
integrate responses to environmental stimuli at the level of promoter function 7
To examine the relative importance of protein kinase A in NT/N promoter
function, a CAT fusion gene driven by the wild type NT/N promoter (-216/+56)
was transiently expressed in both A 126-1 B2, and PC12 cells treated with the
indicated inducers (Fig 3). In striking contrast to the induction of CAT
expression in response to combinations of inducers inPC12 cells, the promoter
was effectively silenced in A 126-1 B2 cells.
Lithium has previously been shown to substitute for NGF in the cooperative
regulation of NT/N gene expression in PC12 cells 6, 7, The results presented
here demonstrate that both lithium and NGF influence the expression CAT fusion
genes driven by promoters containing either AP- 1 sites or CREs. Most striking
is the ability of either NGF, or lithium to selectively activate promoters
containing multiple AP- 1 sites. AP-1 is comprised of a collection of related
proteins typified by the products of the c-fos and c-jun proto-oncogenes 10, 11
Recently, Jun-B has been shown to activate promoters containing multiple, but
not single AP-1 sites when transfected into F9 embryonal carcinoma cells 12 , In
contrast, c-jun activated both types of promoters, but c-jun activation of
promoters containing single AP-1 sites was inhibited by co-expression of Jun-
. .j\ '
112
B. NGF simultaneously and rapidly activates the transcription of the c-fos, c-
jun, and Jun-B genes in PC12 cells 1, 2, 3, 4, 5. Thus, the selective activation
of genes controlled by multimerized AP-1 sites in response to NGF may be due to
the coordinate induction of c-jun and Jun-B gene expression by NGF in these
cells.
The expression pattern of the NT/N gene in PC12 cells suggests that additional
promoter configurations may confer specificity in responses to particular AP-
complexes. Mutational analysis of the NT/N promoter indicates that a single
consensus AP-1 site and two CREs function interdependently to integrate the
effects of multiple inducers 7. The mutually dependent functioning of these
elements, coupled with the differential effects of NGF and lithium on promoters
containing AP-1 sites and CREs, suggests strongly that the single AP-1 site
within the NT/N promoter functions within the context of the NT/N promoter by
cooperating with adjacent CREs. The cAMP pathway is indispensable for NT/N
promoter function since the promoter was inactive in a mutant PC12 cell line
deficient in protein kinase A activity. The major CRE-binding protein in PC12
cells, CREB, is structurally related to the c-fos and c-jun proteins 13, 14 and
could specifically interact with one or more AP- 1 protein.
The striking effect of lithium on promoters containing multiple AP-1 site
suggests that lithium treatment may also induce genes encoding AP-
transcription factors. AP- 1 sites mediate responses to phorbol esters in certain
cell types 15 suggesting that lithium may act through its well established effects
on the phosphatidylinositol (PI) signal transduction pathway 16 Lithium
amplifies agonist-stimulated inositol phosphate accumulation in PC12 cells
resulting in the accumulation of inositol mono- and polyphosphates, although not
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inositol- 1,4, trisphosphate which mobilizes intracellular calcium 17
GH3 pituitary cells, lithium enhances the agonist-stimulated accumulation of
diacylglycerol, the intracellular messenger required for the activation of protein
kinase C 18. NGF also stimulates PI hydrolysis and a transient increase in
protein kinase C activity in PC12 cells 19, 20. Thus, both agents could exert
their effects, at least in part, throtlgh the PI pathway.
The effects of lihium on gene expression may be particularly relevant to its
dorsalizing effects on developing amphibian embryos 1 6 Lithium potentiates
growth factor induction of mesoderm in isolated animal cap tissue at an estimated
, ,
intracellular concentration of 6.4 mM 21 Similar concentrations of lithium (5
mM) potentiate NT/N gene expression in PC12 cells, although maximal effects
are observed between 10 and 20 mM 6 . The cooperative effects of lihium on
NT/N gene expression and the forskolin- induced activation of promoters
containing CREs suggest that lithium could also potentiate the growth factor-
induced expression of specific genes involved in mesodermal differentiation.
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FIG. 1 Lithium and NGF selectively activate promoters containing multiple AP-
sequences. a, PC12 or mutant A 126-1 B2 cells were co-transfected with either
pBLCat4, 1 xAP- , or 5xAP- 1 plasm ids (depicted schematically), and a
standardization plasmid in which the firefly luciferase gene is controlled by the
Rous sarcoma virus long terminal repeat 22. Following a 48 hr recovery
period, transfected cells were treated with the indicated combinations of inducers
for 12 hr, followed by determination of CAT and luciferase enzyme activity.
Representative CAT assays for each plasmid and induction condition are shown.
NA, no additives; F, 10 JlM forskolin; N , 100 ng/ml NGF; L, 20mM LiCI; P, 100
nM PMA. b, Fold induction of CAT gene activity (average of three separate
experiments) in PC12 cells transfected with either the 1 xAP-1 (open bars) or
5xAP-1 (black bars) plasmid treated with the indicated inducers (as in a). c,
Same as b except mutant A 126- 1 B2 cells deficient in protein kinase A activity 9
were transfected. The average fold induction was calculated from at least two
separate experiments for each condition.
METHODS. Cell culture, transfections, and enzyme assays were all performed as
described 7, 9. The A126-1B2 cells were derived from the PC12 cell line and
are deficient in protein kinase A activity 9. The 1 xAP- 1 and 5xAP-1 plasm ids
were constructed as described 8, except that the vector was pBLCat4 instead of
pBLCat2. They contain either one or five copies of the human collagenase gene
AP- 1 site inserted between vector Hind III and Bam HI sites of pBLCat4. An AP-
1 site within the vector sequence of pBLCat2 has been removed from pBLCat4 (C.
Jonat, personal communication). The AP- 1 core sequence in the NT/N promoter
188 to - 182) is identical to the collagenase AP- 1 site 7. The fold induction
was calculated as the ratio of CAT activity in induced cells to the activity in
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control cells. CAT activity was corrected for assay background, and variations in
transfection efficiency.
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FIG. 2 NGF and lithium potentiate forskolin- induced activation of promoters
containing single or multiple CREs: dependence on protein kinase A activity. a,
PC12 or A126-1B2 cells were transfected with RSV E, 1xCRE, or 4xCRE CAT
fusion gene plasmids (depicted schematically) and treated with the indicated
inducers as described in Fig. 1. Representative CAT assays are shown. b, The
average fold induction of CAT expression in PC12 cells for 1 xCRE and 4xCRE was
calculated as described in Fig. 1 from at least six separate experiments for
4xCRE and 3 separate experiments for 1xCRE and RSVLlE. c, Representative CAT
assay from A 126- 1 B2 cells transfected with 4xCRE and treated with the
indicated inducers as in Fig. 1.
METHODS. The 1 xCRE, and 4xCRE CAT fusion gene plasm ids were constructed as
described 23 by inserting synthetic oligonucleotides encompassing the vasoactive
intestinal peptide CRE upstream of an enhancerless RSV promoter , RSVLlE. This
CRE contains two inverted copies of the sequence CGTCA which is identical to the
distal CRE sequence (- 147 to - 143) in the NT/N promoter 7. Other methods are
as described in Fig. 1.
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FIG. 3 Activation of the NT/N promoter by combinations of inducers is dependent
on protein kinase A activity. A CAT fusion gene controlled by the wild type NT/N
promoter (-216/+56, depicted schematically) was analyzed in both A 126- 1 B2
and PC12 cells treated with the indicated inducers (abbreviated as in Fig. 1
except; 0, 1 mM dexamethasone; F, 1 mM forskolin). CAT assays, and the actual
% conversion of 14C-chloramphenicol from unacetylated to acetylated forms are
shown.
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This thesis examined the structure and regulation of a neuroendocrine peptide
gene encoding neurotensin (NT) and neuromedin N (N) in PC12 cells. Previous
studies had shown that induction of NT peptide and NT/N mRNA levels in PC12
cells are strictly dependent on simultaneous exposure to combinations of NGF
dexamethasone, forskolin, and lithium (Dobner et aI., 1988). To examine the
transcriptional component of this complex regulation, the rat NT/N gene was
first cloned and characterized (Chapter II). Next, the cis-regulatory sequences
necessary for expression in PC12 cells were delineated using transient
transfection assays, performed on plasm ids containing NT/N sequences fused to
reporter genes in PC12 cells (Chapter III). Finally, to address the mechanism of
synergy between these inducers, the NT/N promoter and promoters containing a
single functional class of cis-regulatory site were analyzed in wild-type and
protein kinase A-deficient PC12 cells (Chapter IV). In this chapter, those
analyses are reviewed and a model is proposed to explain the transcriptional
regulation of the NT/N gene in PC12 cells. Also, the relevance of this work to
three important issues in neurobiology are discussed, including (1) phenotypic
plasticity of the neural crest, (2) NGF- induced neuronal differentiation , and
(3) the pharmacological actions of lithium.
Progressive deletion of the NT/N 5' flanking region revealed that sequences
between positions -216 and +56 function to integrate the transcriptional effects
of all four inducers. These sequences, termed the NT/N promoter, are sufficient
to confer the full spectrum of responses exhibited by the endogenous gene to
reporter genes, including the absence of basal level expression , the negligible
response to single inducers, and the extraordinary synergy between combinations
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of any three and all four inducers. We conclude, therefore, that the NT/N gene is
subject to complex synergistic control at the transcriptional level by all four
inducers.
Cooperative interactions in the transcriptional control regions of other
complex promoters have led us to consider two basic mechanisms for the
synergistic control of theNT/N promoter: (1) synergy at the level of the gene,
and (2) synergy at the level of signal transduction. As an extension of the model
proposed by Ptashne (1988), synergy at the level of the gene could involve
induced or activated transcription factors which cooperatively bind to adjacent
sites in the promoter, or independently bind those sites and cooperate through a
third factor (Ptashne, 1988). Alternatively, the effects of inducers may
converge at the level of signal transduction to increase the synthesis and/or
post-translational modification of a transcription factor which regulates one or
more sites in the NT/N promoter. The functional characteristics of the NT/N
promoter and its constituents suggest that synergy can occur at both levels.
Detailed mutational analysis of the NT/N promoter provided direct evidence
for the functions of several inducible cis-regulatory sites, including an AP-
binding site (AP-1), two cAMP-responsive elements (CREs), and a
glucocorticoid responsive element (GRE). The severity of specific mutations in
the AP- 1 site or either CRE suggest that these sites function in a mutually
dependent manner. The GRE may also cooperate with the other sites, but the
evidence is less convincing. Furthermore, the biased effects of specific
mutations in the NT/N promoter suggest that each of the three classes of sites
mediates a distinct function. Mutations in either of the CREs resulted in
selectively attenuated responses to combinations of inducers that include
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forskolin, suggesting that these sites function as cAMP-responsive elements,
while internal deletions which remove part or all of the GRE consensus resulted
in selectively attenuated responses to conditions that include dexamethasone,
suggesting that it functions as a glucocorticoid-responsive element. In contrast,
extensive mutations in the AP-1 site did not show biased effects, suggesting that
more that one inducer activates the AP-1 site. However, due to the apparent
synergy between the AP-1 site and the CREs, it remained uncertain what the
effects of individual inducers were on these sites.
To characterize the roles of the AP-1 site and CREs in the NT/N promoter
more clearly, CAT reporter genes fused to promoters containing either a single
copy or multiple copies of an AP-1 or CRE site were evaluated in parental and
mutant PC12 cell lines treated with forskolin , NGF, and lithium, individually,
and in combination. The results indicated that these two types of sites are
regulated independently, and can be distinguished by: (1) the selective effects of
single inducers; (2) the combinatorial actions of inducers; and (3) the
requirement for kinase A activity. Each distinction , discussed separately below,
could have significant bearing on the role of these sites in the NT/N promoter.
First, a comparison of the effects of single inducers on promoters containing
either AP-1 sites or CREs suggests that each inducer preferentially activates one
type of site. Promoters containing five AP-1 sites, but not a single AP-1 site,
were markedly induced by lithium (58-fold) and NGF (nearly 20- fold), and
modestly induced by forskolin (S- fold). In contrast, promoters containing
either one or four CREs were induced by forskolin (3- and 9- fold,
respectively), but were unresponsive to either lithium or NGF, individually.
Therefore, lithium and NGF might act principally through the AP- 1 site, and
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forskolin might act principally through on the CREs, in the NT/N promoter.
These results corroborate the effects of specific mutations to the AP- 1 and CREs
in the NT/N promoter, suggesting that multiple inducers activate the AP-1 site
and forskolin principally activates the CREs. In addition, the selective activation
of promoters containing multiple AP-1 sites by these single inducers, and the
synergy between the AP-l and CRE sites in the NT/N promoter, suggest that the
function of a single AP-1 site is dependent on the activity of adjacent sites, in
PC12 cells.
Further distinctions between the functions of AP-1 and CRE sites were
revealed with combinations of inducers. Our result indicate that all three
inducers act additively on promoters containing multiple AP- sites.
contrast, lithium and NGF potentiate the forskolin- induced activation of
promoters containing four CRE (6-fold and 2-fold, respectively), and similarly
affect promoters containing a single CRE. Interestingly, the potentiating effects
of lithium and NGF on CRE activity also appears additive in cells treated with all
three inducers. Therefore, separate mechanisms may mediate the effects of each
inducer on both the AP-1 site and CREs.
The role of cAMP-mediated signal transduction in the induction of these
promoters was further implicated using a mutant PC12 cell line. deficient in
protein kinase A activity (van Buskirk et aI. , 1985). We observed that CRE
activity was silenced and forskolin- induced expression from promoters
containing multiple AP-1 sites was compromised. However, the effects of
lithium or NGF on promoters containing multiple AP- sites was only
marginally impaired. Therefore, forskolin effects on these promoters are
mediated by a protein kinase A-dependent mechanism, while the transcriptional
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effects of lithium and NGF are mediated by both kinase A-dependent and kinase A-
independent mechanisms. These results confirm the role of kinase A in the
forskolin-stimulated cAMP pathway (Montminy et aI., 1986; Rowland-Gagne and
Greene, 1990; van Buskirk, et aI., 1985), and support the role of multiple
independent signal transduction mechanisms in the response to NGF (Cremins et
aI., 1986). Moreover, since a CAT fusion gene driven by the wild-type NT/N
promoter (-216/+56) was effectively silenced in kinase A-deficient cells we
conclude that the cAMP pathway is indispensible for NT/N promoter function, in
PC12 cells.
Our evidence suggests that lithium and NGF influence NT/N gene expression
through distinct mechanisms involving one or more AP- 1 binding proteins. This
conclusion was drawn from several observations. First, mutations to the AP-
site in the NT/N promoter severely compromise NT/N promoter activity.
Secondly, lithium and NGF selectively activate promoters containing multiple
AP-1 sites, additively. This selective activation of multiple AP-1 sites closely
resembles the properties of an NGF- inducible AP-1 protein, Jun B, recently
demonstrated in F9 cells (Chiu et aI., 1989), also NGF- inducible in PC12 cells.
Thirdly, recent studies by Bryant Bullock have shown that the rapid and
transient peak in unspliced NT/N precursor RNA in PC12 cells treated with a
combinations of NGF, dexamethasone, and forskolin occurs earlier than in PC12
cells treated with a combination of lithium, dexamethasone, and forskolin. This
earlier peak was protein synthesis- independent while the later peak was protein
synthesis-dependent. These results suggest that NGF's actions on the NT/N
promoter could involve a post- translational modification of pre-existing
transcription factors while lithium actions could involve the increased
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expression of transcription factors. In PC12 cells, several members of the AP-
1 family are differential regulated in response environmental stimuli , such as
forskolin and NGF (Bartel et aI., 1989; Chiu et aI., 1989). Some are post-
translationally modified, also (Curran, 1988). Combinatorial mechanisms
between AP-1 proteins might play a critical role in mediating the pattern of
response of the NT/N promoter to various combination of inducers. Overall, the
characteristics of the NT/N promoter suggest that different AP- binding
proteins with similar functional properties are activated by lithium and NGF
through separate mechanisms involving transcription or by post-translational
modification. Although , it remains possible that the protein induced at the
transcriptional level by lithium could also be post-translationally modified by
The selective effects of specific mutations to cis-regulatory sites in the NT/N
promoter which closely resemble GRE and CREs suggest that the glucocorticoid
receptor and a major CRE-binding protein found in uninduced PC12 cells
(CREB), respectively, could be involved in NT/N gene expression in PC12 cells.
The glucocorticoid receptor is a ligand-dependent transcription factor which
directly mediates the effects of dexamethasone through GREs (Evans, 1988).
CREB , on the other hand, is activated by phosphorylation at a specific residue
(Ser- 133), recognized by kinase A , in response to cAMP (Gonzalez and
Montminy, 1989). Phoshosphorylation of CREB at Ser-133 appears to activate
an allosteric mechanism which may enable CREB to interact with other
components of the transcription apparatus (Yamamoto et aI., 1990).
Phosphorylation at a separate site, by protein kinase C, promotes CREB dimer
formation and enhances its binding affinity, but not its ability to active
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transcription, in vitro (Yamamoto et aI., 1988), suggesting that additional
phosphorylation mechanisms might also modulate CREB functions, in vivo.
However, since dephoshorylated CREB can stil bind as a monomer to the CRE, and
since evidence suggests that CREB monomers and dimers exist in equilbrium 
un induced PC12 cells, it has been proposed that CREs are bound constitutively by
CREB (Roesler et aI., 1988). If CREB is involved in the regulated transcription
from the NT/N promoter, then the potentiating effects of lithium and NGF on
forskolin- induced CRE activity could involve converging phosphorylation
mechanisms on CREB proteins, previously bound to the NT/N promoter. An
alternative possibility is that other CRE-binding proteins may mediate the
effects of forskolin , NGF, and lihium on the CREs.
CREB is a member of a family of transcription factors which are
structurally-related to AP- (Hai et aI., 1989). Two other CREB-related
proteins have been clonedand are present in PC12 cells: CRE-BP1 (Maekawa et
aI., 1989) and LlCREB (Yamamoto et aI., 1990). Eight recombinant cDNA clones
encoding CRE-binding proteins have been characterized in HeLa cells, differing
in their precise interactions with a consensus CRE (Hai et aI., 1989). The
potential for interactions between the two families is supported by recent
evidence that c-Jun and Fos/Jun dimers can activate transcription through CREs,
in F9 cells (Chiu et aI., 1989) and J EG-3 cells (Sassone-Corsi et aI. , 1990).
However , there is no solid evidence that specific heterodimers, which form
between members of the CREB and AP- 1 families, activate transcription from
either site (Benbrook and Jones, 1990; Ivashkiv et aI., 1990; MacGregor et aI.,
1990), or that CREB can bind and activate the AP- 1 site (Deutsch et aI., 1988;
Hoeffer et aI., 1989). We speculate that since promoters containing AP- 1 sites
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or CREs are differentially regulated in response to these inducers, and mutations
to these sites in the context of the NT /N promoter have distinct effects, it is
unlikely that both types of sites are mediated by the same transcription factor. It
is more likely that distinct proteins mediate the effects of the CREs and AP-
sites in PC12 cells.
The model that I propose to accunt for the complex regulation of NTIN gene
expression in PC12 cells, depicted schematically in Figure 1 , is based on the
following considerations: (1) all the information necessary to confer appropriate
transcriptional regulation to heterologous promoters occurs between postions -
216 and +56 of the NT/N gene; (2) the NT/N promoter is composed solely of
inducible cis-regulatory sites, including an AP- 1 binding site, two cAMP-
responsive elements, and a near-consensus glucocorticoid- responsive element;
(3) the AP-1 and the CREs are mutually interdependent; (4) each inducer has a
dominant effect on one type of site through a separate pathway (dexamethasone
affects the GRE, forskolin affects the CRE, and both lithium and NGF affect the
AP- 1 site); (5) interactions occur between the cAMP pathway, activated by
forskolin , and the pathways activated by lithium and NGF such that all three
inducers influence both the CREs and AP-1 site; and (6) distinct transcription
factors could mediate the activity of each type of site. This model accounts for the
undetectable basal level of expression , the absence of an appreciable response to
single inducers, and the extraordinary synergy between combinations of three
and four inducers. Each of these features are addressed separately, below.
I propose that combinations of the four inducers could act synergistically to
induce NT/N gene expression in PC12 cells at the level of the gene and at the level
of signal transduction. At the level of signal transduction. lithium and NGF
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synergistically potentiate the effects of forskolin on CREs. At the level of the
gene, multiple transcription factors induced at the transcriptional level and by
post-translational modification, cooperate to increase the rate of transcription
from the NT/N gene. Whether these transcription factors bind each site
cooperatively or bind independently and then interact cooperatively through a
third protein is unknown. . However, two observations suggest that the spatial
organization of the NT/N promoter is important for the regulation of the NT/N
promoter. First, the organization of the NT/N promoter is such that all four of
these sites roughly align on one side of the DNA helix, in a position which could be
favorable for interactions between different transcription factors. Secondly, the
NT/N promoter sequences between -216 and -28 function in either orientation
upstream of a heterologous promoter but are silent when moved downstream
from the reporter gene. These results suggest that the apparent synergy between
the AP-1 site, the CREs, and possibly the GRE may reflect interactions between
stereospecifically aligned proteins which contact the transcription apparatus.
Moreover, the severity of mutations in the AP-1 site and the two CREs indicate
these sites must be occupied in order to generate high level expression. In this
model, the complex pattern of responses to the various combinations of inducers
reflects the particular assembly of transcription factors at the NT/N promoter at
once, and their capacity to activate transcription.
I propose that a productive assembly of transcription factors does not occur on
the NT/N promoter, in response to individual inducers, as a consequence of either
weak binding sites in the NT/N promoter, or the properties of transcription
factors which activate transcription from those site. Three sites in the NT 
promoter, the GRE and both CREs, deviate slightly from their respective
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consensus sequence. In other systems, identical or nearly-identical deviations
from the CRE and GRE consensus exhibit weaker activity (Bokar et aI., 1988;
Jantzen et aI., 1987). Often, such weak sites function cooperatively with
adjacent active sites in complex promoters (Comb et aI., 1989; Hyman et aI.,
1989; Jantzen et aI., 1987; Lee et aI., 1987; Mermod et aI., 1988).
addition, sequences flanking AP-1 and CRE consensus sites have been shown to
markedly affect their capacity to respond to phorbol esters and cAMP,
respectively (Deutsch et aI., 1988; Hoeffler et aI., 1989). Therefore,
activation of the NT IN promoter in PC 12 cells may involve cooperative
interactions between weak binding sites. However, the alternative possibility is
that each site may have high affnity for its transcription factor, but due to its
specific biological properties, stil not form a productive transcription complex
in response to single inducers. In support of this possibilty, Jun-B has been
shown to bind a single AP-1 site (Nakabeppu, et aI., 1988), but not activate it
(Chiu, et aI., 1989). Furthermore, it appears to outcompete an activator of that
site, c-Jun (Chiu et aI., 1989). Similarly, a CREB-related protein expressed in
PC12 cells, ilCREB, binds the CRE equally as well as CREB, but unlike CREB
cannot activate it (Yamamoto et aI., 1990). Both of these proteins could serve to
downregulate AP-1 and CRE activity in general, or modulate specific gene
expression, like the NTIN promoter.
I propose that the transcription factors which regulate the NT/N promoter are
either absent or inactive in uninduced PC12 cells. The glucocorticoid receptor is
cytoplasmic in the absence of hormone (Yamamoto, 1985), the levels of AP-
protein are low in uninduced cells (Sheng, 1990), and CREB requires
phosphorylation to be induced to activate transcripiton (Yamamoto, et aI.,
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1988). In this regard, the NT/N promoter can be considered solely composed of
inducible cis-regulatory sites. However , in other cells types, these sites could
be constitutively active (Lee et aI., 1987; Roesler et aI., 1988). The strikingly
different patterns of expression of the NT/N promoter in rat GH3 pituitary cells
and Rat 2 embryonic fibroblasts, particularly the response to forskolin
treatment in GH3 cells and the high constitutive activity in Rat 2 cells, attest to
the flexibilty of this gene.
Analysis of the NT/N promoter has demonstrated that very complex regulatory
properties can result from the assembly of different inducible cis-regulatory
sequences near the start site of transcription. Such modular organization is
common among transcriptional control regions for protein coding genes in
mammalian cells. In general, promoters and enhancers are composed of multiple
cis-regulatory sites activated by both constitutively active and inducible
transcription factors (Dynan, 1989). However, the NT/N promoter is thus far
unique in that it appears to be composed entirely of inducible elements. These
inducible elements serve to integrate multiple environmental stimuli into a
unified transcriptional response. During neural crest development, such a
mechanism may be particularly important for the generation of phenotypic
plasticity. Pluripotent neural crest cells may maintain a battery of genes, in
accessible chromatin conformation , which are expressed only when cells receive
specific combinations of environmental cues (Anderson and Axel , 1985).
Exposure to the appropriate environmental cues would result in differential gene
expression and culminate in a particular differentiated phenotype. Furthermore,
synergy between several environmental cues provide a more sensitive
mechanism to control the magnitude and duration of the response through small
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changes in the concentration of individual inducers. Therefore, promoters
composed entirely of inducible elements could engender both specificity and
flexibilty in the transcriptional response to combinations of environmental
stimuli.
The NT/N promoter has provided insight into the mechanism by which NGF
mediates neuronal differentiation in PC12 cells. One of the earliest responses to
NGF in PC12 cells is the rapid, transient, and protein synthesis- independent
induction of several genes encoding putative regulatory proteins, including
members of the AP-1 family. This rapid transcriptional activation of AP-
expression has led to the proposal that these proteins are involved in the cascade
of transcriptional events which occur during NGF- induced neuronal
differentiation (Sheng, 1990). The observed induction of AP-1 components in
specific regions of the brain following chemically- induced seizure suggests that
these proteins may also mediate neuronal function (Morgan and Curran, 1989).
The presence of a functional AP- 1 site in the proenkephalin promoter and the
slightly delayed appearance of proenkephalin mRNA following seizure suggests
that AP-1 proteins may be involved in neuropeptide gene expression in the brain
(Sonnenberg et aI., 1989). The functional AP-1 site in the NT/N promoter, and
the fact that the NT/N unspliced precursor RNA is induced with slightly delayed
kinetics relative to the induction of AP-1 genes in the absence of protein
synthesis. implies that AP- 1 proteins play role in NT/N gene expression.
Furthermore, the selective activation of multiple AP-1 sites by NGF suggests
that promoters containing multiple AP- sites, or a single AP-1 site in the
context of active CREs, may be involved in NGF- induced neuronal gene expression
in PC12 cells.
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The data presented in this thesis demonstrate clearly that lithium ion
influences specific gene expression at the transcription level, in PC12 cells.
lithium, present in trace amounts in normal serum, is the major therapeutic
agent used in the treatment of manic depressive ilness in humans and a potent
teratogen during early development (Berridge et aI., 1989). Although
investigations into its mechanism of action have focused on its inhibitory effects
on signal transduction involving the cAMP and phosphoinositol pathways, the
consequences of these effects on gene expression have received little attention.
The ability of lithium to selectively activate promoters containing multiple AP-
sites by a kinase A- independent mechanism, and to potentiate forskolin- induced
CRE activity markedly, by a kinase A-dependent mechanism, indicate that at least
two distinct signal transduction pathways mediate lithium transcriptional
effects, including the cAMP pathway. Although the concentration of lithium used
in these experiments (20 mM) was greater than peak serum levels during
lithium therapy (1 mM), the observation that lithium can potentiate NT/N gene
expression submaximally, in vitro, at much lower concentrations (2-5 mM)
(Dobner et ai., 1988) raises the possibility that lithium- induced changes in
neuromodulator or neurotransmitter gene expression in the central nervous
system might participate in its pharmacological effects.
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Figure 1. Model for the transcriptional regulation of the NT/N gene
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ADDITIONAL SEQUENCE DATA
Unpublished sequence information, compiled during the structural analysis of
the rat NT/N gene and bovine hypothalamic cDNA, is presented below. The first
schematic serves a reference of the fragments subcloned from the rat gene
(Figure 1). The sequencing strategies and linear sequence of two subcloned
fragments, a 1.8 kb EcoRI/Hind III fragment and a 2.2 kb Hindlll fragment, are
depicted schematically (Figure 2a, b). The 1.8 kb fragment contains a portion of
5' flanking sequences, Exon I, and sequences up through approximately 500 bp
from Exon II. The 2.2 kb fragment contains the better part of Intron II and part
of Exon III. Figure 3 depicts that analysis of 1.4 kb of NT/N .5' flanking region.
Figure 4 depicts the sequence analysis of the bovine hypothalamic cDNA.
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75Kb Hindlil/Hindl1i
0Kb BamHIIBamHI
Scale
1 Kb Hindlil/Hindll1
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20Kb Hindlll/Bgli1
- O.8Kb Hinfl/Hinft
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cloned fragments
added RE site
- 1.25Kb BgIII/B9111
- O.9Kb B9111/BgIli
- 1. 1 Kb B9111/B9111
- O.5Kb HinflHinfi
75Kb Bg11I/Bg11I
Figure 1: Structure of rat NT/N gene and subcloned fragments
161
S H
EXON 1
1 61 +1751
GAATTCCCCG GATCGTCACT TTCAATCAAG GTTCATGGGT GGGGGATGAG
ATGAGGGACA AAGAGAAGG AGGGGGGATG GAGATGAAGG CAGAGCACAT
101 CCTGTACAGT CATGACATCA CCCTCCTGCT CACGTATATA TAGGGCATGG
151 CCAGAGCATC TCTCACAGTT CACTCACTTT CAAGCCAGCT GAAGGCAAGA
201 GGAAGCACCA AGAGAGCTCC TTCCGTGTCT GTGTGGACCT GCTTGTCAGA
251 AGGCTGAGAG AAGATGATAG GAATGAACq TCAGCTGGTG TGCCTGACTC
301 TCCTGGCTTT CAGCTCCTGG AGTCTGTGCT CAGGTAAGCT CGCACCTCTC
351 TGAAGTGAGT GATTTCTCTT ACAGTCTGCT GCTACTCAGG TAATGAATC
401 CCAGGAGGAA TCTCTCTCTC TCTCTCTCTC TCTCTCTCTC TCTCTCTCTC
451 TCTCGTATAA GAACTGAAC TATTATTTTT TTTTCTTTTA AAAGTCTGTA
501 AAGCAGGCAG TTCATGAGGT TTCAAGGAA GGCAACTAT TTTCCTTTGG
551 AATATAACTA CTAGAGGGAA AATCAATAA GAGTAATAA ACAAGGATGA
601 AACTAGAAC AGAGGCAGAG CTTTTCAGCA GGCTCCCATG AAGAGATCTC
651 ATGCATGATT TTTTATTCTC ATCTTTTCTC ACTGCCTTAG CTGGTGGCTT
701 CTCTCACTTA CCTTTGTGAT TTTCCTCAAG TTATTTTCAA CTCTACATGT
751 GTGTTAGAAC ATGTGAATA AATACCAGTA AATAAGAG TGTTTCTAAT
801 GCAACAA GTGTCCCAAG TCCTTTGAGA ATGTATATTT TAAGAATTT
851 CATTCTGACA GTCGTGATGC TCATATAGCT GCTGCTTTTT TGAATGTAAT
901 CTAAGTTGGC ACAACTATAA CCATAATT GGTATACTTC TATTTATGAT
951 AATTTAGCT TTACAGTGTT CTGTATATAA CAGTTAAGAA GAAGAATGT
1001 ATTGTTATCA GATGAATTAC GTCTTCTTAA AATAATA AATTTAAGAC
1051 TAATATGAA TATTTTGATG ATGGCAATGT ATTTTAATTA ATAATTGGAA
1101 ATAATTGAAC AACACCTAA CAGTGGAA TCTTAAGAC AAATGAAGT
1151 AATCACT TAACTTATAT TTGTGAATAT TGTTCTTAAT AACCAAGACT
1201 CTGAAGTGTT AGTTCCAAC TAAGATTTTT TTAATACAA AGATTAGCTA
1251 TCAGAAGTTT ATCAGACTGT GATATGTTTT GGATGATCTT ATTAGTATAA
1301 GAGCCTGTAA ATATTTTATA AGCCAATGGC ACTTTCCCAT AACTATAATT
1351 TTATCAAGTA GTTTACAGAA ATATAGTTCT AATTATAGCT TATTGATTAA
1401 AATTGTATA TTAGCTCTCG AACCCATTT CTGTGACATA AACACATTCT
1451 T AACAGAGA T TAACAAGATT AATTTTTAAC ATTCATTCTG AAATCAAC
1501 AGCAACAA TGGAGCAA GTGTCCCTGG AATAGCTCAG TTCTTACAGG
1551 TACTCAGGCT GGGATCTTGT GTTTTAAGA CCACATAGTA AATAATGGGG
1601 CAATTTT AAG CTCTGCCTCC TTTATCCACA GAAGGCTAAT GGATATTAA
1651 TGCTCTACAA TACCTTAGCG TTTCTAAGTT TTTGCTTCTC T AAACAAGAC
1701 ACATAAGA AATCTGGGAA AATGTGTTCT GACATTAATC AAGGATCTGT
1751 TTTCAGTAGA TTTAGCATGT GTCGATGGGA GCTCTGCCTT TGCTTAAGCTT
Figure 2a. NT/N gene sequences including exon and a portion of intron 1.
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TTTATTTAGT
CAAGGTAGGA
GAAGCCCTTG
CATGTTGACA
GCAAGGTCTA
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EXON 3
162
ATTCGATCCC GGTAACAGTG ACTGCAGTCT
AGATGGGTGT AACCCATTAA TACTATCTTA
GTGTCTTACA ATAGGTTTTG TTTTTGAAT
CATACATGCT CTAATAATC CTGAACAT
CCATTCTTAA ATATGGGAGA ATATGGGTTC
TGTGCCATGG TGTGATTCAA TCAGTCTAA
TTGCATTGCA CATTGACTCA TTTCAACTTA
TAGTTACCTA AGACACTTCT TCAACAAGAA
TGCAATTTGC TGCTAGGATA AATAA
TTGTTTCTGT TATTCAACCA TAATTTTTGT
501
551
601
651
701
GAACTATGTG AGAACTCTAA ACATATGTCT ACTTTAACCT
XXXXXXGAG TCCAGGAATC AATAGAATGA AATAAGA
ACAATTTGTT CGTGTCTCAC AATACATTTT TTAATTATC
TTGGAATATA GGGTCATGAA GAGTAGTCCT AATTTAGCAT
TAATCAACA GAATCCCGG TATATGCTAG TTCAGTGCAG
751
801
851
901
951
AGTAACTAGA ATACAGAATA
AAGTTGTTGA AATAATTCAA
TCACAGGTAG TGGGTTTTTA
AACACACTTG ACAAGGCTTA
ACTTTCCTCA AATGTATTAT
1001 AGCTTTATTT
1051 AGAATAGAT
1101 ACTTTCAGTG
1151 ATTCTCTTCT
1201 TTTCCTACTA
1251 TCAGGATATT
1301 GAAGTAA
1351 CAACAGAGC
1401 ATGCACACAC
1451 AGGCCATTGA
1501 GAACCTCCGT
1551 CCATTTCAGT
1601 ATTCTCACGG
1651 TCTTAGGTTC
1701 GAGCATTACA
1751 ACTTGCTTGA
1801 AGACATCTGC
1851 TGGAATGA
1901 CGCAGCGGAG
1951 GGAACTTCC
2001 GTATTCCAAC
CTGGCAGGAC
GTGAATGAAG
TTCAATGTG
CTCCTCTTCT
ATCTACATGT
TAA TTAAT
TTTAAGGCA
CCAGACTCAG
ATACGTGTAT
ACCTAAGAGT
GAGAATGGAG
TTAAGGAAC
AGGTTTCCCT
A TTGGACCTC
CGTTATGTGT
GTTCTGGCTC
CATTTTAAT
CCTTGCTCAA
GAAGCGGGAG
CCTTGTCCTG
TCCAGAA
CTCTCATGCT
GTGTATCTGA
TATGTCACAT
ATCCTTTACT
CTCTTTGTAA
GCACATTTTG
TAACTTTTTG
ACATCATATT
CTCTTCATCT
GAGTATTTGC
CTTCCCTACT
TATATACTTT
TTACCTGCGT
ATAATAACA
TGGAAGGGCT
GAGGAAGTTG
TCCTCGCTTC
CCTTCCAAGT
GTTTGTTTTA
GCACAACGCA
GTTTATAAG
GCAAGGAAG
CTGATCAATA
TGACGACCTT
GCTTGGAAGC
TTTCGTACTC
GCTTAGCTAT
TGTAATGTA
GACAAGTTTT
CCTCTCTGAC
ACAATCCAAG
GTTACTAAGA
CATATGAGGT
GTGCATGTTT
AATGTTTATA
AATGACTAXX
CAACACAGG
ATCACTGGCA
GTTATTTTTG
GCTTTGAATA
GATTCTCGTT
GTTCAGTGAG
TTAATAAGGA
TAGACATTAA
TTCTCTGCTC
ACAGTTAGAC
TCCTCCCCCT
CTTCTTTTCC
CTGCTCTTCT
ATGTAAGTC
TTTTGTAAGT
ATAACACCA
TTGTGCACAC
AACGAAGA
TTGAAGGAGG
ACGTTAGTTT
CTCTTCCTCC
TTTCCCACAC
TTATTGTTGG
GGTAATGCA
TTATATATAC
TCCTCCCTCT
ACCTGAACAG
GTTGCGAA
GCTGCTGACC
Figure 2b. NT/N gene sequences including intron 2 and part of exon 3.
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1414 +56
-1414 AAGC TTTTTTTTTT
-1400 TTTTTTTTTG CCACAGAAC ACAACAA ATTAAGTAA TGGAACTA
1350 AACTACTGT TTAACTTTTG AACATTGAGT TGAATTAA TATCTTTTAT
-1300 TATTTAAC AACTGTTCAA GTTTTGTAAC TAATGATTTC CTCTAAGGGA
-1250 AAGATAATC TCTTACCAA TACTGGATAT " TTAACCAAC TGTCTGTAGT
-1200 AACAATAATG ATTTTTTTCC TTAGTTATTA TTTACATGAT TAGTGGGGTT
-1150 TTTTTT AAGAATAA TCGGATCTCA GAATCTTTG GTTTTAGATA
-1100 TTCATATTCC TAATACCAGT TCAGGACACT TCTTGTATTA GCAAGGATCC
-1050 TCTCGGACAA GCTATGCCTC AAAGGCGTT TGAGCAATT TTCTTCCAGT
-1000 AATCAAGAGA AGGAAGAAT ATCATTGTAA TAACAAGTTA CCTGAAGATT
-950 CTCTCTTAGA GATGTGACTC CGGTGGTTGC TAGTTATAT GACTATTTTC
900 TGTCTAAGT ACAGTCACTT TTCTACAAT AAGGATT AACTGAAGG
-850 GAGAGAGTGC TAAGGGAGTT CTGAATGAA GGAGAGAGGA AGATACAGTA
800 TCGGACAACA AATAACAGT TAATGTA GTAATGT GATTAATTAT
750 GAATTAATT GGGGAGGTAT AATTAATACA GCATTCATAG TTACCTTTGA
700 TGCATAACCT ATTTGTGCCT CTATTTTATA AATATTATTT AACACCCA
650 TGAAGACAG CATATGAATT TAGACTCCCC TCAGCTACAT ACATAACTT
600 TCAAGAAGT AGGACATAAT ACTATTCATT AGATCTTCAA TTTCCTTCCT
-550 TTTATCTGAT ATTTTTCCTT T ACCTTGGAT GTTCTGTTAC CCTATTCCAT
-500 TATTATATTC ATTTTCTTTT GTCTGTTCCC CTTCCTATTT TTAGTACATG
-450 CTATAAAA TTCTTTATGA GTTTTGAGAC CAGAACACG TGCTCAAGAA
-400 GTTTGTGTTA CCAGAAAATA TACCCCAAGT CTTTGAGTCT TCCAAGCAGT
-350 GATATCTCTC TAGAACTTTT GCTTATATAT TAGGAATAAA AAAACCCCA
300 CATTTTTAA ATCAATGAC AAATGTCTGG AGCACGATAG GGATTAGAAA
250 TAAGGTAC CGGGTGCCTC TTCCTAGCTG TACACTGCAG TGCTTTTGAA
-200 CAACTCTTTC CGTGAGTCAG AAACCCTGAG CAACAGCTGC AATTAGGGAA
-150 GATCGTCACT TTCAATCAAG GTTCATGGGT GGGGGATGAG ATGAGGGACA
100 AAGAGAAGG AGGGGGGATG GAGATGAAGG CAGAGCACAT CCTGTACAGT
-50 CATGACATCA CCCTGCTC GTATATATAG GGCATGGCCA GAGCATCTCT
CACAGTTCAC TCACTTTCAA AGCCAGCTGA AGGCAAGAGG AAGCACCAAG
+51 AGAGCTC
Figure 3. The NT/N gene 5' flanking region.
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5' 
BHNT CODING REGION 
101
151
201
251
TAGAGAGCCC
GAAGGCTCAA
CTTCTGGCTT
GAAGCGTTA
GTAAGGCAAG
CTTATAATA
CCTTCAGCCT
GATGATGGCA
TCAGCTCCTG
GAACAGATT
TGTTCCCTCT
ACCTGAACAG
GTTCCTGACG
GGAATGAA
GAGTCTGTGC
TACTGACCAA
TGGAATGA
CCAAGCTGAG
TTTATGAACT TGGCTTGCTA
TCCAGCTGGT GTGCATGATT
TCAGATTCAG AAGAGGAAT
TATGCATACA TCAAGATCA
GCCTGCTGAA TGTCTGCAGT
GAACAGGAG AGTTTCATGA
301
351
401
451
GGAGGAGCTC ATTACAAGAA GGAATTTCC
GCTTGGAAGC AATGTTGACG ATATACCAGC
AGGGCCTTTC AACACTGGGA GTTGATTCAG
AATGACAA AATGAAGG AAGAAGTGAT
TGCTGCCTTA GATGGTTTTATCCAAT CTGTCACAGC
GAAGACATTC TTGATGCTGG
AAGAGAA ATTCCTTACA
501
551
601
651
701
GCAGCTTTAT GAGAATAAC CCAGAAGACC CTACATACTC
CTTACTACTA CTGAGAGGAT AATATTTTA TTTACATGTG
CTTTTAATGA AATATCAAT TATATTTGTG TGGAATGTG
ATTATTTTGT CTCTTCTACA GTTGTGGTTT ATTAGATGTG
GCATTACTAT AATTGGACT AATGTTTTA AATAATCT
TTCTGAACG
AAGAGGTT
ATTGTGATTT
ACAGAGCACA
ATTTTTTTCT
751
801
851
901
951
TGTGTATAAT TGGAGTAGAT ATTAATTAAG
TTTTGCAAG CACTTAATGG GTTGTTCAAG
CTAACCAA TTAAGAGA TTAGGACAGT
ACCTGTCATT AACCCAGAAC AAGTAACAC
TTCATTGAAC TGAACACAT GCGCTTTTCC
AGATCTTGAG CATGAATGT
TCACATAGAA TGTTTTGTCA
CAGTTAAT GTTTGCCATT
TTTACCGCAA AGTCTAGCCT
CTGTTTTATT ATTTGAATGT
1001 AAGACTTACT
1051 GGACCATCTT
1101 TAATGAATGA
1151 GCTAATAA
CATTAATCTC AGAATGGGG
CAAGAATGA TTAATGAATT
TCTTAGACTG AATTTGTTTT
ACACAA
AAGGCAATAG AAGTAATA
ATTGTTAATT ATGCGTGTCT
TCTGTTAAT GAATTTAATA
Figure 4. Bovine hypothalamic NT/N cDNA
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TRANSIENT TRANSFECTION ASSAYS
PC12 cells have been successfully tranfected in several laboratories by a
number of methods including protoplast fusion, calcium phosphate co-
precipitation, and electroporation. The major advantages of the electroporation
technique over these alternatives are simplicity, reproducibility, and higher
efficiency (Chu et aI. , 1987). Technically, electroporation involves the exposure
of a cell suspension to a high-voltage, high current, exponential pulsed electric
field which , presumably, causes temporary pores to form in the plasma
membrane and allows DNA to enter the cell. A single exponential pulse of
controlled characteristics can be delivered using the Bio-Rad Gene PulserT M
(BIO- RAD Laboratories) transfection apparatus. In this thesis, all transfection
experiments involved electroporation. The following parameters were optimized
to achieve maximal transfection efficiency, as measuered by reporter activity.
ect opo n v taQe/capac . The three parameters which have major
impact on transfection efficiency by electroporation are voltage, capacitance, and
buffer system. As a rule, voltage-dependence for maximal efficiency changes with
buffer and capacitance. In all experiments reported in this thesis, cells were
electroporated in1.0 ml 80% phosphate buffered saline (Delbecco s PBS)/20 
10 mM Tris- HCI(pH 7.6),1 mM EDTA solution containing supercoiled plasmid
DNA isolated by cesium chloride gradient centrifugation.
To establish the optimal voltage in kilovolts (kV) and capacitance in microfarads
(JlFD) required for maximal transfection efficency (survival and expression of
CAT activity) in PC12 cells, the positive control plasmid pSV2CAT was used. The
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SV40 early transcription region drives the expression of chloramphenicol
acetyltransferase (CAT), in SV2CA T (Gorman et aI., 1982). Capacitance affects
transfection efficiency by determining the amount and duration of the current
pulse passing through the cell suspension. Voltages between 0. 35 kV were
surveyed at the maximum capacitance of 960 IlFD (Fig. 1 a). The data indicate
that the 0.2kV/960IlFD condition yields optimal expression of CAT and survival
by electroporation. Next, the optimal capacitance was determined at 0.2kV and
0kV (Fig 1 b). The optimal survival and CAT expression occurs at 0.2kV and
9601lFD. Therefore, the maximal tranfection efficiency appears to occur at 0.
kV and 960 IlFD with approximately 25% survival. The calculated field strength
is 0.5 kV/cm.
d t n. In order not to limit cellular components involved in
the expression of CAT activity in transfected cells, transfection efficiency should
increase linearly as a function of DNA concentration. Because preliminary
experiments had indicated that the NT/N-CAT 5' deletion plasm ids with endpoints
between - 1414 and -216 were equally inducible in response to a combination of
the four inducers (dexamethasone, forskolin , NGF, and Li), plasmid -216 was
chosen to demonstrate the linearity of transfection by electroporation (Figure 2).
The results indicate that transfection efficiency is linear through 50 Ilg.
AT kin . To assure that CAT enzyme activity is linear throughout the
assay, a time course was performed as in Figure 2 using 5' deletion plasmid -
1414 (Fig. 3). The data indicate that CAT enzyme activity is linear through 90
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min and that acetylation of the label remains linear through at least 60%
conversion.
ase p To control for variations in transfection
. efficiency, a luciferase plasmid was co-transfected with the test CAT plasmid. The
plasmid PS-LUC was driven by the NT/N gene cis-regulatory sequences from -
216 to +56. To determine the minimal concentration of this luciferase plasmid to
use as a normalizing standard, increasing concentrations of PS- LUC were co-
transfected with the promoterless CAT vector , pUCAT (Fig. 4). The inductions and
analysis were as in Figure 3. Luciferase activity was linear through at least 10
jlg. To minimize potential competition for inducible transcription factor
between the CAT and luciferase plasmids, a 10:1 (CA T:LUC)DNA ratio was chosen
for all subsequent experiments.
Recove Kin Preliminary experiments had suggested that recovery
post-transfection by electroporation was critical for maximal response to a
combination of all four inducers. To establish the optimal recovery period post-
transfection for maximal responses, PC12 cells were co- transfected with the CAT
and luciferase plasmids bearing NT/N seqences from -216 through +56, and
allowed to recover for 12, 24, 36, and 48 hrs, prior to a 12 hr induction with
all four inducers (Fig. 5). The results suggest that the optimal recovery period is
48 hrs following electroporation for response to all four inducers. However, it is
not known if activity continues to increase beyond a 48 hr recovery.
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duct n Kinetics. The optimal time to analyze the response to a combination
of all four inducers (Fig. 6) was established in PC12 cells as in Figure 5.
Induction of both CAT and luciferase activity appear to peak at or near 8 hrs.
Differences in the stability of reporter gene transcripts or their products may
explain the plateau in CAT activity and the rapid decay in luciferase activity. A 12
hr induction time was selected since CAT activity is optimal and since luciferase
activity serves as an internal standard.
Cur t t sfect otocol. The following protocol results in the efficient
transfection and optimal expression in response of the NT/N control region fused
to reporter plamids in PC12 and GH3 cells.
Cells are harvested at half confluence in ice cold phosphate buffered saline
(Dulbecco s PBS). Twenty million cells in 800 III are combined with 200 III of
10 mM Tris-HCI (pH 7.6), 1 mM EDT A containing 25 Ilg of CAT plasmid with 2.
Ilg of luciferase control plasmid for 10 min on ice, followed by a single pulse
from a 960 IlFD capacitor charged to 200 volts in a 0.5 cm cuvette ( BioRad).
After a 10 min incubation on ice, the transfected cells are resuspended in ice-cold
PBS and pelleted to remove debris and DNA precipitant at 1000 rpm , 5 min at 4
C. For analysis of more than six conditions, paired transfections are pooled and
plated onto six-well plastic culture dishes (5-6 conditions/transfection cuvette).
The cultures are allowed to recover for 48 hrs prior to induction in 2-3 mls of
fresh medium. Following a 12 hr induction , the cells are triturated from the
plate in ice-cold PBS and pelleted in an Eppendorf tube at 4 oC, for 10 sec. The
pellet is rinsed with 1.5 ml of PBS, spun again, and resuspended in 100 III of 100
mM potassium phosphate (pH 7. 8). 1 mM DTT. The cells are lysed with three
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freeze/thaw cycles (liquid nitrogen/37 ' water bath). Cell extracts were
analyzed for protein content, then CAT and luciferase activity as described above
(see CHAPTER III, methods). Wagner PC12 and A 126-1 B2 cells were
transfected identically; except, the concetration of CRE, AP-1, and luciferase
plasmids was double. The transfection protocol used for the RAT2 cells was
essentially the same with the following modifications. 107 cells were transfected
in the identical solution with 25 Ilg of CAT plasmid and 5 or 10 Ilg of luciferase
control plasmid. Electroporation of DNA was performed using a single pulse from
a 960 IlFD capacitor charged to 300 volts.
Cell cu PC12 cells were grown in 100 mm tis ue culture dis
(Corning) in Dulbecco s minimal essential medium (OM EM) supplemented with
10 % horse serum, S % fetal bovine serum, 50 Ilg/ml streptomycin, and 50
U/ml penicillin (all from GIBCO). GH3 cells were also grown as described
(Lufkin and Bancroft, 1987) in the above media. Wagner PC12 and A126-1B2
cells were grown in DMEM supplemented with 10% fetal bovine serum , 5% horse
serum , 501lg/ml streptomycin , and 50 U/ml penicillin. RAT2 cells were grown
in DMEM supplemented with 5% newborn calf serum (Hazelton, Lenexa, KS).
GH3 and RA T2 cells were cultured on poly- Iysine (SIGMA) coated plates.
Routinely, cells were split 1:3 every two to three days in fresh complete medium.
The concentrations of inducers used were nerve growth factor (100 ng/ml),
dexamethasone (1 IlM), forskolin (1 IlM), lithium chloride (20 mM), and
phorbol 12-myristate 13-acetate (60 ng/ml), unless otherwise stated. NGF was
either prepared as described (Mobley et aI., 1976) or purchased from
Bioproducts for Science, Inc. (Indianapolis, IN). Dexamethasone was gift from
y;c.
ft,
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ji'
171
Merck , Sharpe, and Dohme. LiCI was from Fluka. Forskolin and phorbol 12-
myristate 13-acetate (PMA) were from Sigma. A concentration of 10 J.M
forskolin was used in experiments involving the CRE and AP-1 plasmids. All
cells, excluding the GH3 cells, were incubated at 37 oC and 8% C02. The GH3
cells were incubated in 5% C02. All cell cultures were split to approximately
50% confluence (.:: 07/100 mm plate) in fresh media 24 hrs prior to
transfection.
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Figure 1. Electroporation efficiency as a function of voltage and capacitance in
PC12 cells. 4 x 106 PC 12 cells were transfected with 25 g of pSV2cat by
electroporation and analyzed following 64 hrs of transient expression. Cells were
harvested in 0.25M Tris- HCI, resuspended at 107 Iml and disrupted by
sonication. Percent survival was determined following transfection relative to
control (untransfected) cells, prior to sonication. Cell extract from
approximately 5.5 x 105 cells (55 I) were analyzed in a 90 min CAT assay. a.
Electroporation as a function of voltage at 960 FD capacitance.
Electroporation as a function of capacitance at 0.2 kV and 2. kV.
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Figure 2. Electroporation as a function of DNA concentration. PC12 cells were
electroporated with a single pulse generated from a 960 I1FD capacitor charged to
200 volts applied to 107 CAT activity was determined following transfection of
between 1-50 I1g of a NT/N-CAT fusion plasmid (-216). Twelve hours post-
transfection, PC12 cells were induced for 48 hrs with either all four inducers
(100 ng/ml NGF, 1 11M dexamethasone, 1 11M forskolin, and 20 mM liCI) or no
inducers in fresh media, and then harvested as in Fig 1. CAT assay were
performed with 20 I1g of cell extract. Duplicate transfections were averaged and
plotted.
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Figure 3. CAT activity as a function of time. PC12 cells transfected with a NT/N-
CAT fusion plasmid containing 1.4 kb of NT/N gene 5' flanking sequences (-
1414) and induced with either all four inducers or no inducers for 48 hrs (see
Fig 2). CAT activity within 10 Ilg of cell extract was used at each time point
indicated.
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Figure 4. Luciferase activity as a function of DNA concentration. PC12 cells were
co- transfected with 25 g of CAT plasmid -216 and increasing amounts of PS- LUC
into 20x1 07 cells as indicated. Transfected cells were induced and analyzed (see
Fig. 2). Luciferase and CAT activity was determined with samples of 20 g of cell
protein and normalized to the CAT activity.
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Figure 5. Induction of CAT and luciferase activity as a function of recovery time
post-transfection . CAT activity in % conversion (upper panel) and luciferase
activity in light units (lower panel) were determined from 20 119 of cell extract
taken from triplicate inductions of PC12 cells co- transfected with 25 Ilg of
NT/N-CA T plasmid -216 and 2.5 Ilg of PS- Iuc. PC12 cells treated with a
combination of all four inducers (closed boxes), as in Fig 2, or no inducers PC12
cells (open boxes) were collected and analyzed 12 , 24 , 36, and 48 hrs. post-
transfection. Background subtracted and averaged activity is plotted with standard
error bars.
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Figure 6. Induction kinetics of CAT and luciferase activity. PC12 cells were co-
transfected with the -216 plasmid and PS-Iuc (see in Fig. 5). Forty-eight hours
post-transfection fresh media including either all four inducers or no inducers
was added. Following a 1, 2, 4 , 8, 12 , 16, 20, and 24 hour incubation , CAT
(closed boxes) and luciferase activity (open boxes) were determined. No change
in uninduced CAT or luciferase activity occurred (data not shown).
TIME (HRS)
60000
50000
40000
30000
20000
10000
184
